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GENERAL INTRODUCTION 
Huntington's disease (HD) is an inherited, progressive, 
neuropsychiatric, degenerative disorder which predominantly affects 
the basal ganglia and cerebral cortex. The onset is usually in adult life, 
frequently after offspring have been produced. 
Others (1,2) had noted the disease earlier in the nineteenth 
century, but Dr George Huntington, a General Practitioner of Long Island, 
New York , wrote the definitive description in 1872 (3), at the age of 22 
years, one year after his graduation from Colombia University. 
'I recall it vividly .... Driving with my father through a wooded road ... we 
suddenly came upon two women, mother and daughter, both tall, thin, 
almost cadaverous, both bowing, twisting, grimacing. I stared in 
wonderment, almost fear .......... . 
.... The hereditary chorea, as I shall call it, is confined to certain and 
fortunately few families and has been transmitted to them, an heirloom 
from generations way back in the dim past. It is spoken of by those in 
whose veins the seeds of the disease are known to exist, with a kind of 
horror, ......... It is attended generally by all the symptoms of common 
chorea ............ . 
.. .. .. .. .. .. .. There are three marked peculiarities in this disease: 1. its heredi-
tary nature; 2. a tendency to insanity and suicide; 3. its manifesting itself 
as a grave disease only in adult life.' 
Folstein (4) found no convincing descriptions of this disease 
in the ancient writings. She raises possible explanations: that the first 
mutation may have occurred in the Middle Ages, and that the human 
life span may have been too short to reveal the hereditary nature. 
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Further, she speculated that Huntington' s description of the disease re-
ceived ready acceptance because it arrived at a time when doctors were 
beginning to appreciate the concept of heredity. But, the brilliance of 
Huntington' s report should also be acknowledged. On this matter Sir 
William Osler (5) commented, 'there are few instances in the history of 
medicine in which a disease has been more accurately, more graphically 
or more briefly described.' 
Adams and Victor (6) state the disease can be distinguished 
by the triad of dominant inheritance, choreoathetosis and dementia. 
Stanley Fahn (7) also describes a diagnostic triad, but he omits the 
dominant inheritance feature and adds 'emotional disturbances' to 
chorea and dementia. There are dangers in attempting to simplify the 
symptoms of the disease. The 'emotional disturbances' overlooked in the 
first mentioned triad are frequently the most difficult symptoms. 
Further, Mattsson (8) and Hayden (9) found that patients first presented 
with psychiatric symptoms alone, more often than with neurological 
symptoms alone. In the early stages irritability and impulsivity are 
evidence of personality change. Depression of both reactive and organic 
origin occur, and suicide is not uncommon. A schizophreniform psychosis 
may be the presenting complainl and delusions and hallucinations may 
continue to be troublesome. In addition to chorea, Folstein (4) has 
described other involuntary movements (motor restlessness, dystonia, 
tremor and myoclonic jerks) and abnormalities of voluntary movements 
(eye movements, fine motor coordination, speech, dysphagia and gait). 
The brain displays a symmetrical and severe atrophy 
involving predominantly the frontal and temporal lobes. Atrophy may 
also extend into the parietal and occipital lobes. The lateral ventricles 
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are enlarged, particularly the frontal horns. The caudate is severely 
atrophied and may be concave where it projects to the surface of the 
lateral ventricle. Histologically there is diffuse neuronal loss in the 
cerebral cortex, basal ganglia, thalamus, inferior olives, and anterior 
horn cells of the spinal cord (10, 11). 
The biochemical events are unclear. The most consistent 
finding is a reduction in brain GABA content (12). The literature 
contains conflicting reports of changes is the various neurotransmitter 
systems. Borison et al (13) suggested this may be explained by the fact 
that HD is a progressive disorder, and analyses are being performed on 
brains obtained at different stages of illness. 
The impact of this disease on other members of the affected 
person's family is profound. Hans and Gilmore (14) stated that while 
some children do not inherit the gene, none 'escape the disease'. Folstein 
(15) found there was a high frequency of conduct disorder in the 
children of affected individuals and attributed this to the social 
environment of the home rather than the early expression of the gene. 
Hans and Koppen (16) have drawn attention to the impact of the disease 
on the unaffected spouse. 
The difficulties of young people living 'at risk' are now 
receiving attention (17). In Australia discussion groups and support 
activities are organised in every state by the local branch of the 
Australian Huntington' s Disease Association. 
A most important advance in the field was the discovery 
( 18) of a marker linked to the Huntington gene on the short arm of 
-10-
chromosome 4. Subsequently, the ethical and policy issues have been 
discussed (19,20,21), and adult presymptomatic (22) and antenatal 
foetus testing has become available (23). 
Major difficulties arise from the fact that the G8 probe 
attaches close to the Huntington gene and allows only a linkage test. This 
means that blood (DNA) is required from various generations and that, 
at best, the results are less than 100% accurate. This situation causes 
practical and ethical problems. The widely held view is that as soon as 
the abnormal gene can be precisely identified, it will be a simple, 
rapidly achievable task to determine its function and thence an effective 
treatment. Ad vice from experts in molecular genetics confirms that the 
identification of the abnormal gene is probably only two years away, 
but they caution that a treatment is not an easy consequence, and is 
unlikely to follow with great rapidity. 
This introduction has avoided the issues of prevalence, 
fertility, ages of onset and death, and other issues, including early 
diagnosis, which are the subject matter of this thesis. 
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THESIS INTRODUCTION 
This compilation of papers is the product of five years of 
research and clinical involvement in Huntington' s Disease (HD) in 
Tasmania. 
In 1949, Dr Charles Brothers published some details of a 
large, Tasmanian HD pedigree (1). Others performed calculations on his 
figures (2,3) and stated that the region had one of the highest per capita 
rates in the world. Later, the Department of Psychiatry, of the 
University of Melbourne, took an interest in Tasmanian HD families. 
However, no further information was published until that which appears 
herein. 
In 1986, the author commenced research and clinical 
practice in HD. 
First, the functions of HD Registers (HDRs) were examined. 
This led to the establishment and maintained of an HDR. This, in turn 
called for the establishment of an HD Advisory Committee. These events 
have been described. 
Pure research was subsequently conducted on the 
prevalence of HD in Tasmania, the age of onset, the age of death and the 
duration of the diseas2, the fertility of affected individuals and their 
unaffected siblings, and sundry features of the total HD population and 
of the large HD family earlier described by Dr Brothers. 
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The above findings were used as authorative data in a 
review of the social justice issues of HD in Tasmania. This review 
favourably influenced government policy and funding. 
Concurrently, a study of early detection techniques using 
neuropsychological testing, neurological examination and Quantitative 
(Q)EEG has been running for two years. Final data is not yet available 
and thus results can not be presented, but a single case study of an 
individual examined with QEEG before and after the clinical onset of HD 
is described. 
The appendix contains two sets of data. The first is details of 
the large Tasmanian which at January 1, 1990, extended over 43 meters 
of paper. The second is complete details of the neurophysiological 
results of the single case mentioned above. 
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CHAPTER 1. 
THE TASMANIAN HD REGISTER 
The section of this chapter dealing with the functions of a register 
have been published in the Australian and New Zealand Journal of 
Psychiatry 1989; 23: 161-162. 
a. PREAMBLE 
In 1949 Dr. Charles Brothers, the Director of Mental Hygiene 
in Tasmania, published an internationally acknowledged account of HD in 
the state (1). He reported on five generations of a single pedigree. 
Subsequently, episodes of data collection were supervised by 
Dr. John Weatherly, Psychiatrist Superintendent, Royal Derwent Hospital, 
Tasmania, Dr. Eric Cunningham Dax, Co-ordinator of Community Services, 
Mental Health Services Commission, Tasmania, Dr. Edmond Chiu and Mrs. 
Betty Telscher, Department of Psychiatry, University of Melbourne, and 
Dr. Keith Millingen, Reader, Department of Medicine, University of 
Tasmania. 
Unfortunately, these earlier efforts had been largely wasted. 
Records were frequently either lost, unintelligible (by dint of faded ink or 
'. idiosyncratic inscription)., or contradictory. For example, even the names 
of the individuals on the pedigree illustrated in Dr. Brothers paper were 
missing, and it was believed some of the relationships were inaccurate. 
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The most useful records were those offered by the University of 
Melbourne group. But these too were incomplete, in part inaccurate, and 
limited to certain branches of certain families, in certain localities of the 
state. 
As a useful Huntington' s disease register (HDR) did not exist, 
and establishment of such would require the expendature of effort, time 
and money, a study of the functions of HDRs was conducted. The findings 
have been published (2) and are presented below. 
b. THE FUNCTIONS OF AN HD REGISTER 
1. Diagnostic Activities 
(a) In Clinical Medicine. 
One of the three diagnostic criteria of HD is a positive family history 
(3,4). Thus, the Register is a source of clinically important details, 
especially in isolated or difficult cases (5). 
(b) In Laboratory Medicine 
Recent developments in molecular biology techniques have made 
pre-symptomatic (6, 7) and prenatal (8,3) testing possible. As these 
are linkage tests, DNA (blood) is required from various other family 
members. An HDR allows identification and location of the full range 
of possible participants. (9). Additionally, the HDR is a convenient 
means of keeping a record of those specimens which have already 
been obtained and stored, either in anticipation of, or response to 
earlier, requests. 
2. Clinical Care Role 
(a) Clinical Features 
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Some families have a particular age range of onset and death, and 
characteristic symptom pattern (1, 10). 
(b) Treatment 
When a significant advance in treatment is achieved, an HDR will 
enable workers to identify and locate those who will benefit. 
3. Service Monitoring 
An HDR enables the determination of a regional prevalence (11) and 
then, the appropriate distribution of services. It will also enable as-
sessment of the efficacy of genetic counseling programmes (12) 
4. Research 
An HDR is a collection of information which invites epidemiological 
research. It may also form a basis for experimental research. 
5. Preventive Activities 
(a) Formal Genetic Counselling 
An accurate pedigree is essential for genetic counselling (13 ). 
(b) Informal Genetic Counselling 
The process of keeping an HDR reduces the prevalence of HD. It has 
been found that family members do not understand the true hered-
itary nature of the disorder and welcome advice (5). It has been 
found that 85% of relatives at high risk of having a child with a 
serious genetic disorder are unaware of the risks (14). In the 
process of keeping a HDR, ample opportunities present for informal 
genetic counselling and this prevents disease (15). 
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6. Cost Saving 
Through the prevention of disease, HDR's will save much more 
money than they cost to establish and maintain (12, 16, 17). 
7. Educational Function 
Molecular biology is an unprecedented advance in the diagnosis and 
prevention of a wide range of medical conditions ( 18, 19). From the 
clinician's point of view the genetics of HD is relative simple. The 
HD marker is "arguably the most important application of medical 
genetics so far" (20) and the HDR is an excellent model from which 
to learn. 
8. Morale Boosting Function 
(This additional function was not apparent from the review of the 
literature. It is a useful function learned of through practical 
experience.) 
An HDR has a morale boosting function. Contributing information to 
a HDR gives the lay community the opportunity for constructive 
activity. Further, the existence of a HDR has been observed to bring 
people together and encourage valuable mutual support. 
c. ESTABLISHMENT OF THE CURRENT REGISTER 
There had been episodic pressure by medical practitioners 
(21), members of HD families and the Australian Huntington Disease 
Association, Tasmanian Branch (AHDATas) (22), on the state 
government and government agencies, for assistance. 
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Consequently, the Mental Health Services Commission (MHSC) 
requested the above study and in light of the findings, decided in 
favour of the establishment and maintenance of an HDR. 
The MHSC contracted the author to supervise the task and 
provided an equipment fund and a half-time social worker. The 
AHDAT as also provided two amounts of funds over subsequent 
years. 
d. METHOD 
i. Recording 
As mentioned, many of the records made in the past were 
found to be useless due to loss, illegibility and contradiction. With 
this example in mind, the decision was made to use an established 
coding system (23). Two paper copies were drawn. The master copy 
was held in the author's office and the working copy was used in 
the field. New data was first entered on the working copy and later, 
after consideration, entered on the master copy. This arrangement 
had advantages: a review mechanism in the two stage process of 
data acceptance, and the security of having (at almost all times) 
copies of the data in two separate geographical locations. 
The disadvantages of paper copies of pedegrees include that 
they are physically large and time consuming to access. These 
disadvantages considerably reduces the usefulness of an HDR to 
clinical practioners. 
Accordingly, the decision was made to establish, in addition to 
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the paper copies, a computerised system. After assessment of the 
alternative programmes, "The Huntington' s Chorea Clinical Register 
System V2.2" (HCCRS), developed by the Institute of Medical 
Genetics, University of Wales College of Medicine, Cardiff, was found 
to be the most suitable for the Tasmanian situation. Subsequently, a 
programme for the production of line drawings of pedigrees ("PLOT 
2000") was obtained from the same institution. 
An IBM compatible PC was purchased, dedicated to HD and 
housed in the office of the author. 
Initially, data was entered by the author. Later, research 
assistants were employed in this way. Finally, when the data base 
was accepted as being clinical useful, a part-time MHSC computer 
operator was made available. 
ii. Data Acquisition 
An exhaustive search for data was conducted. This involved 
the following individuals, institutions and methods: 
i. All available previous register material was examined. 
ii. Contact was made with members of all known 
families. 
iii. The cooperation of the AHDATas was sought and 
obtained. 
iv. Records were obtained by the author from: 
1. Royal Hobart Hospital 
2. Royal Derwent Hospital, New Norfolk 
3. Launceston General Hospital 
4. Lindsay Miller Clinic, Launceston 
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5. North West General Hospital, Burnie 
6. Eskleigh Nursing Home, Perth (Tasmania) 
7. St John's Park, Hobart 
8. Aralee Nursing Home, Hobart 
9. Strathaven Home For The Aged, Hobart 
10. Department of Pathology, University of 
Tasmania 
11. Department of Community Health, Uni. of 
Tasmania 
12. Melrose, MHSC, Tasmania 
v. Medical Practitioners with a known interest in the 
field were contacted 
vi. General Practitioners were circulated via the RACGP 
newsletter 
vii. Publicity was obtained by newspaper, television and 
an international conference held in Launceston 
viii. Data was also obtained from Registrar-General's 
Division, Australian Archives, councils, churches, 
museums, libraries and graveyards. 
e. EFFICIENCY OF ELECTRONIC REGISTER 
The HCCRS programme proved to be fast and reliable. By this 
method, the goal of being able to respond to requests for information 
without delay, was satisfactorily achieved. 
There were some 'bugs' in the programme, which episodically 
required the assistance of a computer systems officer. However, these 
were correctable and did not reappear. 
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Some HCCRS options were very slow. For example, the 
'Standard Analysis' option, which is a comprehensive statistical analysis 
of all data on the main file, takes around 12 hours, when the main file 
contains 4000 individuals. However, these delays were restricted to the 
statistical options and do not prevent rapid response to requests for 
information regarding one or a small number of individuals. 
'PLOT 2000' has been of limited use in providing 
diagnostically useful information. However, it has been very useful when 
requests have been made regarding the possibility of obtaining blood 
from relatives for presymptomatic and antenatal testing. 
/,,--
f. UTI&ION OF THE REGISTER 
The HDR has proved to be a useful clinical service. During 
1987, 1988 and 1989 there were 17, 23 and 29 requests for information, 
respectively. The increasing number of requests reflect an increasing 
awareness of the existence of the Tasmanian HDR. 
Requests for information came from two sources: Tasmania 
and mainland Australia. 
Requests from within Tasmania came predominantly from 
treating medical practioners who wanted information to support or 
exclude a diagnosis. On fewer occasion it was sought by young people 
(through their general practioners) to assist with family planning 
decisions. 
Requests from mainland Australia have come from medical 
practioners seeking diagnostic assistance, and from other HDRs. The 
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keepers of other HDRs around Australia, who have individuals of 
Tasmanian origin in their state, have been keen to complete their existing 
information. There have also been requests from mainland workers 
seeking information to be used in presymptomatic and antenatal testing 
programmes. The question in these cases being whether their clients had 
close relatives living in Tasmania who could be approached for DNA 
samples. 
The requests from other HDRs have become less frequent. 
However, the total number of requests are unlikely to decline, 
particularly if genetic testing becomes available locally. 
As far as is known, there was no attempt to obtain 
information from the HDR by any individual, or organisation, for purposes 
other than diagnosis, family planning and genetic testing. 
g. RULES FOR ACCESS TO THE REGISTER 
A danger in maintaining an HDR is that the information could 
be accessed and used to the disadvantage of listed individuals. For 
example, insurance and superannuation have been refused to symptom 
free individuals who were known to be members of HD families. This is 
of great concern in Tasmania because of the small population and high 
prevalence of the disease. On this account, there was reluctance to be 
listed on the HDR by some 'at risk' individuals. 
The MHSC had created a Huntington 's Disease Advisory 
Committee (HDAC) to address issues in the area of HD. This committee is 
the topic of the next chapter. However, for the sake of continuity, the 
rules which it developed for the maintenance of and access to, the 
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computerised HDR, are presented here: 
HUNTINGTON'S DISEASE ADVISORY COMMITTEE 
Rules for Maintenance of and Access to the Computer Register 
of members of Huntington's Disease Families 
1. General Principles 
1.1 The Huntington' s Disease Advisory Committee, a body 
established by the Mental Health Services Commission, 
recommends the establishment of a computer register of 
members of families affected by Huntington 's disease 
for the purpose of data collection and bona fide 
research. 
1.2 All information relating to a person on the register is 
confidential and may be dealt with only in accordance 
with these procedures. 
1.3 When data is provided by any person for the register 
that person shall be given a copy of these Rules. 
1.4 The Chairman for the time being of the Huntington' s 
Disease Advisory Committee shall be such person as is 
appointed by the Mental Health Services Commission. 
2. Maintenance of Register 
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2.1 The Register will be maintained on three (3) separate 
sets of computer discs at the Faculty of Medicine, 
University of Tasmania. 
2.2 The discs must be kept in secure and separate places 
and one(l) at least shall be kept in the safe of the 
Faculty of Medicine. 
2. 3 One copy of the Register shall be kept in a fireproof 
cabinet. 
3. Access to the Register 
3 .1 The following persons may have access to the data in 
the register, 
(a) Chairman of the Huntington' s Disease Advisory 
Committee, 
(b) Any person approved by a meeting of the 
members of the Huntington' s Disease Advisory 
Committee, and, 
(c) Any bona fide researcher provided that the prior 
approval of the Huntington' s Disease Advisory 
Committee has been obtained and that any 
conditions as to the use of data laid down by the 
Huntington' s Disease Advisory Committee are 
scrupulously observed. 
3.2 The persons whose data appears on the register may 
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have access to their own personal data and this personal 
data may be provided by the Chairman of the 
Huntington' s Disease Advisory Committee. 
3.3 With the exception of those persons in 3.1 and 3.2, data 
on a person on the register shall not be given to any 
other person except in accordance with paragraph 4 of 
these Rules set out below. 
4. Request for Information 
4.1 Formal Requests for Information 
4.1.1 
4.1.2 
No request for information from the Register will be 
considered unless the request is from a registered 
Medical Practitioner and such a request must be in 
writing. 
Any information provided by the Chairman of the 
Huntington' s Diseased Advisory Committee must be in 
writing and given with the written consent of the person 
or persons concerned. 
4.2 Urgent Requests for Information 
4.2.1. The Chairman of the Huntington' s Disease Advisory 
Committee may answer requests for information by 
telephone where the Chairman considers it expedient so 
to do. 
4.2.2. In all cases of telephone requests for information the 
Chairman must, 
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(a) obtain the telephone number of the person 
requesting the information and return the call by 
way of verification, 
(b) enter a diary note about the date, time, duration 
and nature of the request for information, and 
(c) make a report to the next scheduled meeting of 
the Huntington' s Disease Advisory Committee for 
consideration. 
4.3 Annual Report on Requests for Information 
The Chairman of the Huntington 's Disease Advisory Committee 
shall annually present the Huntington's Disease Advisory Committee 
by a report on the numbers and types (normal or urgent) of requests 
for information received during the year. 
5. Problems in relation to the Register 
5.1 If any problem arises in relation to the maintenance of 
the register, data thereon or access thereto, the 
Chairman shall in the first instance take such steps as 
are necessary to resolve the problem. 
5.2 Any action taken by the Chairman under 5 .1 must be 
reported to the next scheduled meeting of the 
Huntington' s Disease Advisory Committee for 
consideration. 
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5.3 If the Chairman cannot resolve the problem, the 
problem shall be referred to the Huntington' s Disease 
Advisory Committee for consideration. 
5.4 In all cases where the problems concerns a person on 
the register, this person shall be consulted and may 
attend any meeting of the Huntington' s Disease Advisory 
Committee which considers the problem. 
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CHAPTER 2. 
THE HD ADVISORY COMMITTEE 
a. PREAMBLE 
By early 1987 it became clear that the HDR, storage of blood and 
the possibility of genetic testing were raising new issues which required 
discussion and in-put from a wide range of interested individuals and 
g~oups. 
At that time the author was Clinical Commissioner of the Mental 
Health Services Commission (MHSC) and was influential in the 
establishment of the Huntington's Disease Advisory Committee (HDAC). 
b. ESTABLISHMENT 
The HDAC was established as a statutory body under Section 8 of 
the Mental Health Services Act, 1967. This Section allows the 
appointment of committees to advise or assist the Commission on 
specific matters. 
To achieve depth of interest and experience the HDAC was 
composed of the following: 
1. The Clinical Commissioner (Chairman) or a 
nominee. 
2. A representative of the Australian Huntington' s 
Disease Association, Tasmanian Branch 
(AHDATas). 
3. A health professional from the MHSC staff. (This 
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posi tion ordinarily to be occupied by the rel-
evant MHSC social worker.) 
4. A representative of a Department of the Faculty of 
Medicine, University of Tasmania, other than the 
Department of Psychiatry. 
5. A member of the legal profession. 
6. Such others as may be determined by the MHSC. 
(As the elected representative of the AHDA Tas 
was not an HD family member, the HDAC 
requested the MHS C use this provision to 
appoint an 'at risk' individual.) 
c. TERMS OF REFERENCE 
The MHSC determined the terms of reference of the HDAC to be to 
advise and assist 'on matters generally relating to Huntington' s Disease 
and specifically the ethical and practical issues relating to-
1. maintenance of an HD Register; 
2. access to that Register; 
3. predictive testing; 
4. appropriate research; and 
5. deployment of resources' 
The term of office was two years (Manton, 1987). 
d. DELIBERATIONS AND DECISIONS 
The HDAC met monthly for four months and bimonthly thereafter. 
At the end of two years the MHSC requested the members to stand for 
another term. 
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First, the deliberations and decisions of the HDAC will be reported 
according to the terms of reference set out above: 
1. Maintenance of an HDR 
The HDAC considered the fledgling HDR to be a 
useful and worthy of continuing support. 
2. Access to the HDR 
This topic received lengthy and repeated 
discussion. There was unanimous support for 
measures to preserve confidentiality. A set of 
Rules of Access were developed and widely 
circulated. They have been detailed in an 
earlier chapter. The HDAC accepted the view 
expressed earlier by the AHDA Tas, that a 
dedicated PC be used for the purpose rather 
than a less secure main-frame computer. 
At every meeting the author reported (without 
explicit detail) the number and nature of 
requests received. 
The HDAC inspected the HDR security 
mechanisms. 
3. Predictive Testing 
The HDAC developed the view that, given the 
limited support services available in the state, 
antenatal testing is preferable to 
presymptomatic testing. 
The HDAC recommended the storage of DNA 
against the day the testing became available. It 
took an interest in and inspected the storage 
1 
J 
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f acili ties made available at the designated 
laboratory. 
At the time of writing the HDAC had begun to to 
formulate detailed recommendations on 
establishing antenatal testing in the state which 
are to be presented to the government. 
4. Appropriate Research 
The HDAC initiated one research project. This 
was mail survey of the desire for genetic testing 
among HD family members. This was conducted 
by the AHDA Tas. 
It reviewed and suggested minor refinements in 
the procedures to protect confidentiality of a 
number of studies on HD. 
5. Deployment of Resources 
The HDAC made suggestions to the MHSC 
regarding the deployment of human resources, 
recommending an additional half-time social 
worker be made available for HD services. 
The MHSC accepted this recommendation in 
principle but was unable to accede. (Eventually, 
in mid-1990, due to pressure other than that 
applied by the HDA C, which will be detailed 
later, the services of a half-time social worker 
were acquired.) 
It suggested a part-time computer operator be 
made available and this came to pass. 
It supported and passed on to the MHS C, the 
suggestion of the AHDATas that an HD outpatient 
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clinic be established at the Launceston General 
Hospital. 
It drew to the attention of the MHS C, the need 
for the establishment of genetic counseling and 
and support prior to the commencement of 
genetic testing. 
Finally, the HDAC, spent time on functions best described as 
additional to the foundation terms of reference. As stated, it was 
established to advise and assist the MHSC. In practice it also reassured 
and advised the HD families. It reassured them that the authorities were 
aware of and interested in their problems. Specific examples of 
assistance flowing from the HDAC to members of the AHDATas included 
advice on relatively straightforward legal matters (such as the meaning 
of power of attorney) which the member of the legal profession (Prof 
Don Chalmers) was able to provide. There were also occasions when the 
HDAC could represent both the MHSC and the AHDATas, such as when 
the author wrote to a newspaper to refute inaccurate published 
material. 
e. EVALUATION 
The HDAC has been a very useful organisation. It has conveyed 
informed, considered opinion, on new and challenging issues, to a state 
authority. In addition it has given valuable service to members of HD 
families. 
The establishment of such a body in other states is recommended. 
Having as Chairperson, an individual with a working relationship 
-3 8-
wi th the state authority reduces the sense of impotence which can 
damage the morale of interested groups. Of course, this may create some 
difficulties (which are perhaps best construed as stimuli) for the 
Chairperson. The benefits for the Chairperson include unique insights 
and an entree to a museum of pathology. 
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CHAPTER 3. 
HD POPULATION SURVEY OF TASMANIA 
This chapter is based on data which will be published in 
the Bulletin of the Human Genetics Society of Australiasia 
1990; Volume 3: Number 3. 
The data were used by the HDAC in justifying the establishment of the 
Tasmanian Antenatal Genetic Testing Service. 
******************* 
A study was conducted of the total HD population of Tasmania as of 
January lst, 1990. The method of data collection is presented in the next 
chapter which deals in detail with prevalence. The results follow. 
a. SUNDRY TOTALS 
These totals were calculated using all known generations (past 
and present) of all known families. 
Total number of individuals 
in the Tasmanian pedigrees-
Males 
Females 
Individuals Alive 
Individuals Dead 
Affected Alive 
Affected Dead 
Prevalence 
2086 
997 
989 
137 8 
506 
56 
276 
12. 8/100,000 (living individuals only) 
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b. DETAILS OF THE FAMILIES 
There were 14 HD families in Tasmania. The twelfth is extremely 
large and is dealt with at length in Chapter 10. 
FAMILY 
1 2 3 4 5 6 7 
---------------------------------------------------------------
TOTAL IN KINDRED 58 13 37 6 38 24 53 
NUMBER AFFECTED (DEAD) 3 2 3 1 5 4 2 
NUMBER AFFECTED (ALIVE) 1 0 1 0 4 0 0 
NUMBER DEAD 8 3 8 1 19 5 12 
NUMBER ALIVE 50 0 21 0 15 1 0 
NUMBER AT 50% RISK 16 0 4 0 1 1 1 0 
NUMBER AT 25% RISK 21 0 13 0 0 0 0 
FAMILY 
8 9 10 11 12 13 14 
TOTAL IN KINDRED 138 51 42 14 1568 43 4 
NUMBER AFFECTED (DEAD) 18 4 1 3 156 3 1 
NUMBER AFFECTED (ALIVE) 7 0 0 2 40 1 1 
NUMBER DEAD 64 5 4 8 357 1 1 1 
NUMBER ALIVE 73 1 0 6 1179 32 1 
NUMBER AT 50% RISK 20 0 0 4 315 11 2 
NUMBER AT 25% RISK 27 0 0 0 536 18 0 
---------------------------------------------------------------
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c. RISK CALCULATIONS 
i. Simple Inheritance Risks 
TOTAL ALIVE AT 50% RISK- 3 82 
25% RISK- 615 
12.5% RISK- 264 
TOTAL ALIVE AT <25% RISK- 324 
ii. Age Modified Risks 
When the risks are age modified using the Huntington' s Chorea 
Clinical Register System V2.2, the results are as follows: 
TOTAL ALIVE AT >= 40% MODIFIED RISK- 280 
>= 25% 579 
>= 10% 836 
TOTAL ALIVE AT <=10% MODIFIED RISK - 486 
iii. Risk and Reproduction 
By conservative estimate, 186 Tasmanians have a simple inherit-
ance risk of 50% and are 42 years of age or younger. Thus, there are at least 
this many people who could, at some time in the future, request antenatal 
testing services. This number will increase dramatically as almost half will 
develop the disease, and their children (on average, at least 2 for each 
newly affected individual) will then be at 50% risk. 
These chapters have been removed for 
copyright or proprietary reasons. 
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CHAPTER 8. 
THE FERTILITY OF HD AFFECTED INDIVIDUALS IN 
TASMANIA 
This chapter is based on a paper accepted for publication in the 
Australian and New Zealand Journal of Psychiatry 
a. ABSTRACT 
A study was conducted of the fertility (number of live 
births) of Huntington's disease (HD) affected individuals 
compared to that of the general population (using data from 
the 1986 Census of Population and Housing). HD affected indi-
viduals were found to be at least as fertile as members of the 
general population. This finding supports earlier studies. The 
implication for consideration is that once individuals at 50% 
risk have achieved their desired family size, it is appropriate 
to offer reversible sterilization. 
b. INTRODUCTION 
The aim of this paper is to determine the fertility (number 
of live births) of the affected members of the Huntington' s disease (HD) 
families of Tasmania, compared to that of the general population of the 
state. This comparison_ is called the relative frequency (Reed and 
Neel,1959). Accurate relative fertility data are required for scientific 
and planning purposes. 
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Tasmania was identified as a region of high prevalence of HD 
when Brothers (1) published details of a single, large, resident pedigree. 
A recent study (2) found a prevalence in this state of 12.1/100,000. 
This is twice the average occidental prevalence. Tasmania is an island 
with a stable, relatively small population, which is readily accessed. 
With a sophisticated medical infrastructure, it is well suited to popula-
tion health surveys (3). 
c. LITERATURE REVIEW 
Five studies have compared the fertility of affected 
individuals with that of the general population (4,5,6,7,8). Four (5,6,7,8) 
give a relative fertility of affected individuals (AI) over general 
population (GP) of unity or above. See Table 1. 
Reed and Neel (4), wrote an account of HD in Michigan. They 
used general population data from the US census of 1941. They found a 
relative fertility (AI/GP) of 0.9. While elaborate, this was less than a 
total population survey. Surprisingly, they found that affected 
individuals produced about 2.4 children, considerably less than the 4.8 
children of an earlier era (9) and the 5.35 children which can be 
calculated from the smaller study of a later era (10). 
Wallace and Parker (5), working in Queensland, Australia, 
then found affected individuals produced the same number of children 
as did the general, non-aboriginal population, and calculated a relative 
fertility (AI/GP) of unity. 
Shokeir (6), working in the Canadian Prairies, Marx (7), 
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working in Minnesota, and Stevens (8), working in England, found 
relative frequencies (Al/GP) of 1.1, 1.2, and 1.4, respectively. Stevens 
complained that the Registrar-General had published two sets of data 
from the 1961 census of England and Wales. From these he derived two 
versions of the mean fertility of the general population. When his 
higher estimate (2.13 children) is used, the relative fertility (Al/GP) 
remains above unity. 
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RELATIVE FERTILITY 
AFFECTED INDIVIDUALS/GENERAL POPULATION (AI/GP) 
Number of 
Children 
to Affected 
Individuals 
Number of 
Children 
to General 
Population 
Relative 
Fertility 
(AI/GP) 
R+N* M W+P 
2.37 2.97 3.19 
2.58 2.57 3.19 
0.9 1.2 1.0 
R+N : Reed and Neel (1959) 
* : reworked by Marx ( 197 3) 
M: Marx (1973) 
St** 
2.36 
1.73 
1.4 
W+P: Wallace and Parker (1973) 
St : Stevens (1976) 
Sh 
3.78 
3.31 
1.1 
** : using one of two estimates of GP fertility 
Sh: Shokeir (1975) 
Table 1: Fertility of affected individuals relative to the general 
population. 
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d. METHOD 
A field survey of the Tasmanian HD families was 
conducted. Components of the survey included: 
1. Examination of all previously compiled, unpublished pedigrees 
2. Co-operation with the Australian Huntington' s Disease 
Association, Tasmanian Branch 
3. Provision of a Research Social Worker by the Mental Health 
Services Commission, Tasmania 
4. Television and newspaper publicity 
5. Circulation of General Practitioners via the RACGP newsletter 
6. Collection of data from family members, medical practitioners , 
hospitals, nursing homes, Registrar General's Division, Australian 
Archives, libraries, museums, councils, churches and graveyards 
The data collected were the date of birth, disease status 
and blood relationships of the individuals of known HD families. This 
was entered on a Personal Computer using Huntington' s Chorea 
Clinical Register System V2.2, and manipulated using DBaseIII and 
S tatgraphics pro grammes. Fertility was determined by counting all 
the live births by a an individual. 
The general population raw data were taken from the 
Australian Bureau of Statistics 1986 Census of Population and 
Housing. It was the number of children ever born to the women of 
Tasmania who were alive in 1986. It was available in sub-divided 
form, on the basis of the age of the women. The HD groups were 
therefore selected for individuals alive in 1986, whose age and 
number of children were known. Males were included as proxies for 
their partners, and were assumed to be of the same age group. (Males 
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as proxies has been discussed in the previous chapter and the two rel-
evant published papers.) The general population data was adjusted to 
meet the age distribution of the affected individuals. 
e. RESULTS 
Data were available from 26 affected individuals living 
in Tasmania on July 1, 1986. They produced an average of 2. 96 
children. The group representing the general population produced an 
average of 2.85 children. This gives a relative frequency (Al/GP) of 
1.04. See Table 2. 
RELATIVE FERTILITY 
AFFECTED INDIVIDUALS/GENERAL POPULATION (AI/GP) 
Total Tasmanian 
HD Population 
General Population 
No. 
Individuals 
26 
26 
No. 
Children 
77 
74.41 
Average No. 
Children AI/GP 
2.96 
1.04 
2.85 
Table 2. Fertility of the affected individuals of the Tasmanian HD 
population and the Brothers' family, and the general population. 
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f. DISCUSSION 
This method involves the counting of offspring of Ii ving 
people who have at least achieved the reproductive years. A source of 
error is that some asymptomatic heterozygotes will not have been 
counted in the HD group. However, as affected individuals have equal 
or greater fertility, leaving as yet undiagnosed individuals in the 
general population group would only serve to artificially elevate the 
fertility of that group at the expense of the HD group. 
The finding of a relative fertility of 1.04 indicates that the 
Tasmanian HD affected population is as fertile or more fertile (in terms 
of producing more offspring) than the general population. This is in 
keeping with the the most recent overseas studies (5,6,7,8). 
This is especially remarkable given two facts. First, that to 
be included in the HD affected group, individuals must have had 
symptoms, and these symptoms are disabling. Second, that the 
unaffected siblings of HD families have been found to have a relative 
frequency of unity (5,7) or below (4,6,8). 
Thompson and Thompson (11) have observed that natural 
selection against HD is not strong since its late onset age means that it 
does not greatly impair the biological fitness of the heterozygote. In 
fact, there is evidence to suggest that some feature of the disease 
increases fertility (when measured by the number of children born). 
The implication for consideration is that once individuals at 50% risk 
have achieved their desired family size, it is appropriate to offer 
reversible sterilization. 
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CHAPTER12 
THE TASMANIAN EARLY DETECTION STUDY 
The case study in this chapter has been submitted to 
Biological Psychiatry 
a. INTRODUCTION 
Over the last five years, many people 'at risk' for HD have 
come to the author asking to be examined for any signs of the disease. 
They have wanted to know so that they could plan the next phase of their 
lives, reckoning that if the disease is present, they have have a couple of 
years to make sensible, definitive arrangements, and no time to 
commence new, long-term initiatives. This experience arous,ed interest rn 
methods of early detection. 
A distinction is drawn between early detection and 
presymptomatic testing. Presymptomatic testing clarifies whether or not 
the disease will develop, at some time rn the individual's life (1). It is a 
'bigger question', it can only be asked once, and if answered in the 
affirmative, it calls for major personal adjustment. The evidence shows 
that there are many 'at risk' individuals who do not want this question 
applied to themselves. For example, one of the investigators who 
discovered the 08 probe (2) is 'at risk', but has not taken the test. While 
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some surveys (3) have found the majority of 'at risk' individuals declare a 
wish for presyptomatic testing, and some HD clinics have found increasing 
interest (4), others have encountered initial enthusiasm, followed by 
reluctance (5). 
Early diagnosis is an additional service and not an alternative 
to presymptomatic testing. It has value irrespective of whether or not the 
presymptomatic test has been taken. The disease has a variable age of 
onset (6) and individuals who is aware that they carry the abnormal gene 
will still, in many cases, want advanced warning of the commencement 
and staging of the disease process. 
Neuropsychological testing holds promise as a method of early 
detection (7-13). In a recent study using neuropsychological and genetic 
testing (13), five of seven otherwise asymptomatic individuals who were 
found to have inherited the abnormal gene, showed abnormalities in 
visuospatial and frontal lobe function. The age of onset of their affected 
parents was at least twelve years older than the test subjects at the time 
of the reported testing. Taken together, these studies indicate that 
neurophysiological impairment may precede other onset signs and 
symptoms by a number of years. 
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Positron emission tomography (PET) has demonstrated 
impairment of caudate glucose utilization in some subjects who appear, on 
genetic testing, to have inherited the abnormal gene (14). As this method 
allows visualisation of the metabolic function of key structures, it can be 
expected to be useful in early detection. The disadvantage of PET is cost. 
It is not yet available in Australia. Even when it becomes so, the expense 
of each procedure and the inconvenience of traveling form distant regions, 
will reduce its usefulness. 
CT bicaudate ratio studies of established cases have a 
sensitivity of only 77% and a specificity of 92% (15). Thus, this technique 
is of limited value in the early detection of HD. 
Traditional electroencephalographic studies rn established 
disease have been disappointing. Early reports (16) described a loss of 
alpha rhythm and replacement by low voltage slow activity. However, 
only one third of patients display these features (17,18) and false 
negatives have been reported rn 70% of cases (19, 20). Further, the EEG 
abnormalities do not reflect the clinical severity of the disease (21) and 
the follow-up report of a much publicised attempt to predict the disease 
using EEG (22) did not appear. 
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Computerization has made possible a range of relatively 
inexpensive and convenient methods of quantifying and displaying EEG 
data. Such methods have been applied to the study of dementia (23,24) 
and may have a role in the early detection of HD. Neurometrics is a 
method of statistical analysis of standardised, quantitative 
electrophysiological features relative to a body of normative data, 
developed as an aid to the differential diagnosis of a variety of subtle 
brain dysfunctions (25). It has been widely reported in the scientific 
literature (26,27) and is commercially available as the Cadwell Spectrum 
32 and appropriate software. 
b. THE TASMANIAN STUDY 
In 1988 a long-term study into early detection of HD, using 
physical examination, neuropsychological testing and N eurometric 
'Quantitative' (Q)EEG examination, was initiated. The plan was to compare 
baseline data with follow-up data, with a view to discovering early 
features of HD. Subjects will be reexamined at 2 yearly intervals. It is 
anticipated that the study will clarify the progression of 
neuropsychological impairment and provide details of corroborative, 
objective evidence of specific abnormalities of brain electrical activity. To 
increase yield, the subjects are at 50% risk and are between about 30 and 
50 years of age. The diagnosis of HD is made only when both 
psychological/cognitive and physical abnormalities are present. 
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The psychological test battery, devised by Mr Stephen 
Lockwood of the University of Tasmania, after discussion with Prof Nelson 
Butters of the University of California (San Diego) includes, WAIS, Wechler 
Memory Scale, Butters Delayed Recognition Span Test, FAS letter fluency 
test, Category fluency test, Wisconsin Card Sorting Test and Rey Figure 
Test. 
c. PROGRESS 
To the present time, 25 examinations have been conducted. In 
one case neurophychological testing could not be conducted. Three 
individuals were found to have moderately advanced HD and two had 
early, but unequivocal, disease. Nineteen cases showed no abnormality or 
were of uncertain disease status. One individual who was in this latter 
category represented eighteen months later and reexamination revealed 
progression into the unequivocal disease category. 
It is not possible to report the findings of this study as the 
completion of the collection of data is some years a way. However, the case 
mentioned above is unique in the world li tera tu re and is worthy of 
consideration. 
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d. NEUROMETRICS IN EARLY HD: A CASE STUDY 
(The complete results of the Neurometric analyses and comparisons of this 
case are detailed in Appendix II. Only highlights are presented in this 
chapter.) 
A 26 year old, unmarried mother of three, at 50% risk for HD, 
presented requesting assessment of her disease status. Her mother had 
died of HD at 32 years of age and her brother was 28 years of age and 
severely affected. She wanted to determine her current disease status so 
that she could plan the next phase of her life (she was considering tertiary 
education). She complained of, among other things, lack of confidence, 
forgetfulness and clumsiness. 
Medical examination and Neurometric QEEG was conducted. 
Neuropsychological testing could not be arranged. At interview the patient 
was composed and co-operative and, in spite of the presenting complaints, 
no cognitive deficit could be demonstrated using the Mini-Mental State 
(28). Nor was any abnormality detected on careful physical (including 
neurological) examination. 
On Neurometric QEEG the monopolar Z score measures showed 
significantly reduced alpha absolute power and relative power in all 
regions, a significantly red'uced beta absolute power in the parietal and 
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occi pi tal regions, and significantly increased delta relative power in the 
parietal and occipital regions. See Table 1. The bipolar Z score measures 
showed significantly reduced alpha relative power in the central, 
temporal and parietal regions and increased delta relative power 10 the 
same regions. See Table 2. This is consistent with observations using 
traditional EEG (16-18). 
It was also noted that the overall scores in the central bipolar 
regions (C3-CZ, C4-CZ) and the temporal bipolar regions (T3-T5, T4-T6) are 
significantly elevated. See Table 2. 
Version 4.0 of the Psychiatric Discriminants package stated 
that the 'patient's Discriminants Scores lie outside the normal limits 
expected for and individual of this age'. 
The patient returned 15 months later requesting reexamina-
tion. She complained of worsening memory and clumsiness. She said that 
she now disliked going to the city because she got lost and that she spilt 
things and bumped into people as she passed. 
At interview she was still composed and co-operative, but 
there was moderate impairment on the 'Mini-Mental State'. Physical 

Narr1e: GK F 
Age: 27.4 yrs 
Monopolar Z Score Measures 
fpl Fp2 F7 f 8 
Analyzed: 05/30/90 Recorded: 12/02/88 
# Epochs: 38 
F3 f 4 C3 C4 Fpz Fz Cz 
Absolute A -0.47 -0.52 -0.51 0.03 0.58 0.16 1.05 0.26 -0.42 0.42 0.6 
Power e -0.36 -0.48 -0.29 -0.35 -0.45 -0.62 -0.74 -1.14 -0.29 -0.80 -1.3: 
0: -1.93 -1.80 · -2.-42. -Z:,32.. -z.. 73--Z. 89' -2:.13, -2. .. 55' -3. 0-
13 -1.11 -0.61 -0.36 -0.39 -1.31 -0.93 -1.56 -1.14 -1.12 -1.36 -1.8: 
Relative A 0.91 0.82 0.79 1.31ilt..i!f!~ 1.80 0.94 · z_za .. z:· .. 7 
Power e 1.71 1.38 1.48 1.04 0.93 0.92 0.44 0.51 1.73 0.63 0.1· 
0: -z.. 1.Z. -z.. 14 -z.. !. 4. -Z:. 2.?;., -2.~ 84 -Z:. 62;., -3. 43-: -3-.. 32. .-z.. 13· -2.~ 90. -3. 3 
13 0.11 0.78 0.80 0.57 -0.67 0.00 -1.03 0.16 0.06 -0.51 -0.9i 
Power A 
As':::frr1rr1etry e 
0: 
13 
Coherence A 
e 
0: 
13 
0.11 
0.40 
-0.02 
-1. 53 
0.18 
0.67 
-1.09 
-0.32 
!3 T4 
---- ----
Relative A 1.48 
Power 
Power A -0.03 
AS':::fl'lll'letry e 0.07 
0: -0.32 
13 -0.73 
Coherence A 
-
e 
0: -0.59 
13 -0.55 
-0.65 
0. 14 
-0.10 
0.06 
-0.06 
0.53 
-0.40 
0.16 
T5 T6 
1. 95 
1. 05 
0.52 
-0.53 
-1. 22 
0.85 
0.02 
-1. 33 
-0.58 
P3 P4 
W4'+1 
1. 44 
0.74 
-1. 41 
1. 02 
0.37 
-0.46 
0.25 
01 02 Pz Oz 
1.30 0.98 1.19 1.21 1.36 1.01 1.41 
;_3. 10 -a 4z ~3i~ 41 -a. za -z:. a&. ~z~· s4 -3. as -z. ss 
-0.74 0.76 -0.91 -0.40 -0.47 0.11 -0.80 -0.10 
1. 65 1. 05 1. 82 
0.68 0.43 1. 19 
-0.27 0.11 0.73 
-1.04 -0.45 -0.07 
-0.00 1. 38 1. 29 
-0.15 1. 07 1. 09 
-
-0.64 -0.18 
0.80 0.55 
Table 1 
Na.file: GK f 
Age: 27.4 yrs 
Bipolar 2 Score Measures 
Total Absolute Power 
Total Power Asyf!lf!letry 
Relative t>. 
Power e 
()( 
13 
t>.+e 
Corr1bination 
Power t>. 
Rsyrr1rr1etry e 
()( 
13 
Corr1bination 
;oherence t>. 
)verall 
e 
()( 
13 
Corr1bination 
Analyzed: 05/30/90 Recorded: 12/02/88 
# Epochs: 38 
Central TeJ'llporal Parietal 
Occipital 
C3/Cz C4/Cz T3/TS T4/T6 P3/0l P4/02 
----- ----- ----- ----- ----- -----
Iii'~!! -1. 47 -1. 62 -0.86 -1. 76 -1.78 
-1. 61 -1. 58 -0.06 
1. 72 M'4:ICl 1 . 48 •«~ii qt:i:i W.Cf:l 
1.05 0.21 0.86 0.55 1.68 1.63 
C.Jt.JA C..W:W C4*l c•:i C«*l C'4$1 
-0.11 -0.26 1.54 1.61 0.11 0.19 
1.88 ~ 1.39 1.71 i'fl:S:l ....... 
1. 06  1. 3~ W..Wf.l 1. 42 1. 44 
C'~~l C"4f1 -0.08 
-0.58 -1. 21 -0.05 
0.03 -0.92 -0.12 
-1. 24 -1. 38 -0.15 
1. 42 0.80 -4.22 
-0.18 0.07 1. 22 
-1.88 -0.36 0.47 
-0.55 -1. 81 -0.67 
0.60 c<•~ -1.12 
0.96 1. 92 0.38 
-~~l W.Jtij 0.74 
Table 2 
frontal 
Tefllporal 
f7/T3 f8/ 
-----
-1. 31 -0. 
-1. 11 
0.26 -0. 
0.55 0. 
-1. 82 -1. 
1.34 11!1 
0.34 ·-0. 
0. 78 1. 
-0.43 
-0.56 
-0.69 
-1.07 
-0.75 
-0.22 
0. 17 
-1. 20 
C«*l 
1. 00 
0.52 
Na111e: GK2 F 
Age: 28.9 yrs 
Monopolar 2 Score Measures 
Absolute !::. 
Power 8 
[)( 
13 
Power !::. 
Asy111111etry 8 
()( 
13 
Coherence !::. 
e 
[)( 
13 
fpl fp2 F7 
0.63 1. 26 
0.12 1. 02 
-1.29 0.15 
itjQ(a;:~ 0.89 
-~!:l 1. 62 1. 63 1. 16 
-1. 12 -1.04 
-1.20 -0.68 
T3 T4 T5 
f 8 
T6 
---- ----
Relative A lllCJl.il 1.88 
Analyzed: 06/12/90 Recorded: 05/23/90 
# Epochs: 38 Site Id: RHH 
F3 f 4 C3 C4 f pz Fz 
1. 49 1. 84 
0.97 1. 57 
-0.05 0.28 
-0.77 -0.97 
~~l ~!t:i~ 
1. 09 1. 94 
-1.23 0.56 
-0.95 1. 40 
P3 P4 01 02 Pz Oz 
---- ---- ---- ----
Power 8 0.33 0.02 0.62 0.67 0.54 0.54 0.56 1.01 0.31 0.88 
C< pg~ -1. 870Jl.iW4i~!l=f!ill;CftfQB-i:wg!!JSkCl@BE 
13 -1.44 0.16 -1.63 -0.30 ~~.58 -1.64 -0.92 -1.42 -0.51 
Power A 0.59 0.39 0.16 1. 31 
Asy111111etry 8 0.52 0.23 0.27 -0.26 
[)( -0. 18 -0.65 -0.21 0.02 
13 -0.50 -1.63 -1. 01 -0.86 
-Coherence A 1. 75 
-
1. 25 
e 1. 62 ~t!ll 
[)( -1.58 0.93 1. 09 1. 83 
13 -1. 12 1. 77 Rr~!! ~-l:j 
Table 3 
Cz 
''Ja111e: GK2 F 
~g-e: 28. 9 yrs 
3ipolar Z Score Measures 
iota! Absolute Power 
:otal Power Asy111111etry 
Relative ~ 
Power e 
()( 
13 
~+e 
Co111hination 
Power ~ 
Msy111111etry 8 
()( 
13 
Co111hination 
:oherence ~ 
verall 
e 
()( 
13 
Co111hination 
Analyzed: 06/12/90 
# Epochs: 38 
Recorded: 05/23/90 
Site Id: RHH 
Central Tef!lpo:ral Parietal 
Occipital 
P3/0l P4/02 
Frontal 
Te111poral 
f7/T3 F8/'. 
C.§r:i -i. 82 -i. 76 -i. 29 -i. 37 ~4i~l -i. 38 -i.; 
-1.33 -0.90 llif'..:.ftJ -0.22 
W4-j! WB=tl i. 82 •«~ •·s~k1 •«W 0.22 0.: 
0.96 0.23 0.94 0.51 0.50 1. 52 0.62 0. ~ 
C41=l Ott~ c..w~r~ C-4I=J cc-=~! ct..tm -1. 89 -1. f 
-1. 11 -1.79 0.87 0.98 -1. 47 0.49 1. 39 1. f 
•-!Wm l.73••••i=l 0.33 0.) 1. 72 : !i 0. 94 ~ ~ "' ~ 1 . 54 0.89 0. ~. 
C?'..Jt.f:j -1. 45 -=a:i! 0.03 
-0.43 -0. 38 1. 38 0. 15 
-0.04 -0.39 0.11 -0.63 
-0.15 -0.86 -0.53 -0.26 
0.95 0.45 -·~ -1. 39 
0.19 0.13 II -0.59 o•-u -0.42 0.44 -0.62 -1. 25 -1.73 0.74 -1. 52 -1.20 ~ .. i=l 
---~] 0.09 1. 55 1. 83 
•·•!~) 0.91 
-=a-"il 1. 38 
Table 4 
N:a111e 1: GJ<l F 
1ta is GJ<l coMpared to GXZ Na1111e 2: X Gina 
~nopolar Independent Tscore/Diff. Zscore Measures Anal~zed: 06/12/90 
:grees of freedoM: 74 
·-
. 
Fpl Fp2 F7 F8 F3 f 4 C3 C4 f pz f z Cz 
_ ... _ 
---
_ ... _ 
·~--
.... __ ... __ 
....... _ 
~bsolute A -3.6 -2.9 -5.9 -2.4 -4.1 -3.3 -3.9 -3.9 -4.2 -3.4 -3.7 
Power e 0.2 -0.0 -2.2 0.3 -0.9 -0.3 -2.9 -2.5 0.4 -2.3 -0.4 
Tscore) CC 3.7 2.2 1. a 2.2 1. 7 2.5 -0.2 -1. 0 2.1 -0.4 1. 9 
13 5.7 1. 9 1.1 5.0 2.2 3.5 2.8 3.6 2.6 3.1 3.7 
elative A -1. 5 -1. 2 -2.1 -1. 3 -1. 4 -1. 5 -0.9 -1. 2 -1. 5 -1. 4 -0.8 
Power e 1. 1 0.9 1. 3 0.6 1. 1 1. 0 0.5 0.5 1. 5 1.1 0.5 
(A 2) ex 1. 0 0.7 1. 4 0.7 1. 0 1. 0 0.8 0.6 0.9 0.9 0.6 
13 2.0 1. 2 1. a 1. 4 1. 6 1. 6 1. 8 2.1 1. 5 2.0 1. 7 
Power A -0.5 -1. 9 -0.4 0.4 
'::::fl!llltetry e 0.3 -0.9 -0.5 -0.1 
(A 2) ex 1. 3 -0.2 -0.5 0.5 
13 2.3 -0.8 -0.4 -0.4 
he:rence A -2.0 -1. 7 -1. 6 -1. 9 
(A 2) e -1. 0 -0.6 -1.1 -1. 6 
C( 0.0 0.6 -0.1 -1. 0 
13 0.9 0.8 0.4 -1.1 
T3 T4 T5 T6 P3 P4 01 02 Pz Oz 
--- --- --- --- --- --- --- --- --- ---
lbsolute A -6.2 -4.0 -6.4 -8.1 -4.4 -5.0 -8.0 -7.5 -2.9 -6.7 
Powe:r e -5.0 -1. 7 -6.2 -6.3 -3.1 -3.2 -6.6 -7.8 -0.3 -6.5 
Tsco:re) CC -1. 2 -0.1 -4.3 -4.9 -2.6 -3.0 -2.2 -3.3 -2.2 -3.4 
J3 2.9 3.9 -6.9 -8.0 -0.2 -1. 6 -7.0 -7.7 -0.6 -8.8 
•€lative A -2.1 -1. 2 -0.7 -1.1 -0.6 -0.8 -1. 0 -0.8 -0.6 -0.5 
Powe:r e 0.3 -0.1 0.5 0.6 0.4 0.6 0.7 0.3 0.7 0.5 
(A 2) f) 1. 0 0.2 0.4 0.6 0.3 0.3 0.9 0.7 -0.0 0.2 
J3 2.2 1. 4 0.9 1. 1 1.1 1. 2 1. 2 1. 0 0.6 0.4 
Powe:r A -0.6 1. 3 0.9 0.5 
•y111111etJ"'y e -0.5 0.5 0.2 1. 5 
(A 2) 0: -0.1 0.4 0.3 0.7 
/3 -0.2 0.6 0.6 0.8 
ltierence A -4.5 -2.1 -1. 3 0.0 
(A 2) e -5.2 -2.3 -1. 2 -1. 2 
IX 1. 0 -3.1 -1. 7 -2.0 
J3 0.6 -4.9 -1. 3 -2.8 
Table 5 
Na111e 1: GKl F 
~ata is GKl co111pared to GK2 Na111e 2: K 
•ipolar Independent Tscore/Diff. 2score Measures Analyzed: 06/12/90 
•esrees of freedo111: 74 
Absolute A 
Power e (!score) (X 
13 
Relative A 
Power e 
(A 2) C< 
13 
Power A 
lsyrri111etry e 
(A 2) C< 
13 
oherence A 
(A 2) '9 
[): 
13 
Central 
C3/Cz C4/Cz 
----- -----
-0.7 
1. 7 
3.0 
6.3 
-0.8 
0.1 
0.5 
1. 0 
-0.5 
-0.1 
0.1 
-1.1 
-0.4 
1. 6 
0.1 
-0.1 
0.2 
1. 8 
2.6 
6.5 
-0.8 
-0.0 
0.3 
1. 5 
Terriporal 
T3/TS T4/T6 
----- -----
-0.2 
0.9 
-2.4 
3.5 
-0.3 
-0.1 
-0.5 
0.7 
-0.7 
-0.8 
-0.5 
-0.5 
-0.1 
0.1 
-0.6 
-2.1 
1. 5 
3.3 
-0.3 
4.2 
-0.3 
0.0 
-0.6 
0.6 
Table 6 
Parietal 
Occipital 
P3/0l P4/02 
----- -----
-6.1 
1. 8 
1. 9 
6.4 
-1. 7 
1. 2 
1. 3 
1. 6 
-3.8 
-1. 4 
-0.2 
0.4 
3.6 
2.6 
1. 8 
0.1 
4.0 
5.3 
2.5 
5.3 
0.0 
0.1 
0.1 
-0.3 
Frontal 
Terriporal 
f7/T3 f 8/T4 
----- -----
0.6 
0.4 
0.7 
0.1 
0.0 
-0.1 
0.1 
-0.0 
-0.5 
-0.7 
-0.1 
-0.8 
0.4 
-0.3 
0.5 
0.5 
1. 3 
2.0 
0.4 
3.3 
-0.2 
-0.3 
-0.3 
0.4 
Na111e 1: GJ<l F 
~ta is GKl co111pared to GK2 Na111e 2: 
>nopolar Correlated Tscore/Diff. 2score Measures Analyzed: 06/12/90 
~grees of freedo111: 37 
fpl f p2 F7 F8 F3 f 4 C3 C4 f pz Fz Cz 
-- --- --- --- --- --- --- --- --- --- ---
Mhsolute A -3.7 -2.9 -6.2 -2.5 -4.3 -3.4 -4.0 -4.0 -4.3 -3.4 -3.8 
Power e 0.3 -0.0 -2.4 0.3 -0.9 -0.3 -3.1 -2.9 0.4 -2.5 -0.5 
·rscore) IX 3.5 2.1 1. 7 2.1 1. 5 2.2 -0.2 -0.9 1. 9 -0.4 1. 6 
13 5.7 1. 9 1. 1 4.8 2.5 3.6 2.8 3.3 3.1 3.2 3.9 
''.elative A -1. 5 -1. 2 -2.1 -1. 3 -1. 4 -1. 5 -0.9 -1. 2 -1. 5 -1. 4 -0.8 
Power e 1. 1 0.9 1. 3 0.6 1. 1 1. 0 0.5 0.5 1. 5 1. 1 0.5 
(A 2) C< 1. 0 0.7 1. 4 0.7 1. 0 1. 0 0.8 0.6 0.9 0.9 0.6 
13 2.0 1. 2 1. 8 1. 4 1. 6 1. 6 1. 8 2.1 1. 5 2.0 1. 7 
Power A -0.5 -1. 9 -0.4 0.4 
~l'll'letry e 0.3 -0.9 -0.5 -0.1 
(A 2) C< 1. 3 -0.2 -0.5 0.5 
13 2.3 -0.8 -0.4 -0.4 
herence A -2.0 -1. 7 -1. 6 -1. 9 
(A 2) e -1. 0 -0.6 -1. 1 -1. 6 
C< 0.0 0.6 -0.1 -1. 0 
13 0.9 0.8 0.4 -1.1 
T3 T4 T5 T6 P3 P4 01 02 Pz Oz 
--- --- --- --- --- --- --- --- --- ---
lbsolute A -6.2 -4.0 -6.4 -8.1 -4.5 -5.0 -8.3 -7.6 -3.0 -7.0 
lP01.11er e -5.3 -1. 8 -5.9 -7.6 -3.3 -4.0 -6.5 -8.3 -0.3 -6.4 
Tscore) C< -1. 1 -0.1 -4.3 -5.3 -2.6 -3.1 -2.3 -3.5 -2.4 -3.5 
13 3.3 5.3 -6.6 -8.7 -0.2 -1. 4 -6.4 -7.6 -0.6 -8.1 
oelative A -2.1 -1. 2 -0.7 -1.1 -0.6 -0.8 -1. 0 -0.8 -0.6 -0.5 
Jf ower e 0.3 -0.1 0.5 0.6 0.4 0.6 0.7 0.3 0.7 0.5 
{A 2) C< 1. 0 0.2 0.4 0.6 0.3 0.3 0.9 0.7 -0.0 0.2 
13 2.2 1. 4 0.9 1.1 1. 1 1. 2 1. 2 1. 0 0.6 0.4 
1?01.11er A -0.6 1. 3 0.9 0.5 
~l'lfllet ry 8 -0.5 0.5 0.2 1. 5 
(A 2) C< -0.1 0.4 0.3 0.7 
13 -0.2 0.6 0.6 0.8 
iel"'ence A -4.5 -2.1 -1. 3 0.0 
rf..A 2) e -5.2 -2.3 -1. 2 -1. 2 
C< 1. 0 -3.1 -1. 7 -2.0 
13 0.6 -4.9 -1. 3 -2.8 
Table 7 
Nal'le 1: GK! F 
"ta is GK! col'!pared to GK2 Nal'le 2: K 
Lpolar Correlated Tscore/Diff. Zscore Measures Analyzed: 06/12/90 
~srees of freedol'I: 37 
•hsolute A 
Power e 
:Tscore) 0: 
13 
:!elative A 
Power e 
(t:. Z) 0: 
13 
Power t:. 
:y111111etry e 
(t:. Z) 0: 
13 
1herence A 
<t:. z) e 
0: 
13 
Centl""al 
C3/Cz C4/Cz 
----- -----
-0.7 
1. 6 
2.7 
6.9 
-0.8 
0.1 
0.5 
1. 0 
-0.5 
-0.1 
0.1 
-1. 1 
-0.4 
1. 6 
0.1 
-0.1 
0.2 
2.1 
2.4 
6.0 
-0.8 
-0.0 
0.3 
1. 5 
Tel'lporal 
T3/T5 T4/T6 
----- -----
-0.2 
0.9 
-2.3 
3.8 
-0.3 
-0.1 
-0.5 
0.7 
-0.7 
-0.8 
-0.5 
-0.5 
-0.1 
0.1 
-0.6 
-2.1 
1. 6 
3.0 
-0.3 
5.2 
-0.3 
0.0 
-0.6 
0.6 
Table 8 
Parietal 
Occipital 
P3/0l P4/02 
----- -----
-6.3 
2.0 
1. 9 
6.4 
-1. 7 
1. 2 
1. 3 
1. 6 
-3.8 
-1. 4 
-0.2 
0.4 
3.6 
2.6 
1. 8 
0.1 
3.7 
5.2 
2.4 
5.0 
0.0 
0.1 
0.1 
-0.3 
Frontal 
Tel'lporal 
F7/T3 F8/T4 
----- -----
0.6 
0.3 
0.7 
0.1 
0.0 
-0.1 
0.1 
-0.0 
-0.5 
-0.7 
-0.1 
-0.8 
0.4 
-0.3 
0.5 
0.5 
1. 3 
2.0 
0.4 
4.6 
-0.2 
-0.3 
-0.3 
0.4 
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examina tion revealed involuntary movements of the fingers, difficulty 
with rapidly alternating movements, stiff gait, difficulty with standing 
with eyes closed, and increased reflexes in the left arm and both legs, 
with Babinski' s up going on both sides. Neuropsychological testing revealed 
gross impairment. 
On repeat Neurometric analysis the results were similar to 
those of the first examination but the deviation from normative values 
was greater. In the monopolar Z score measures there was reduced 
absolute and relative alpha power in every region, increased delta 
relative power in every region and increased coherence in various 
regions. See Table 3. In the bipolar Z score measures there was reduced 
alpha relative power in the central, temporal and parietal regions, and 
increased delta relative power in the same regions. There was significant 
coherence in various regions. See Table 4. 
The overall scores in the central bipolar region (C3-CZ, C4-CZ) 
were very significantly elevated. See Table 4. 
Version 4.0 of the Psychiatric Discriminants package made the 
same comment as on the previous analysis. 
-157-
The two sets of results were compared (monopolar and 
bipolar, independent and correlated) using T scores of absolute power and 
Z scores of relative power, power assymetry and coherence. See Tables 5 
to 8. Analysis using the monopolar correlated T scores reveals a 
significant increase in delta absolute power over the entire cortex and a 
significant increase in theta absolute power in the temporal, parietal and 
occipital regions. There 1s a decrease in beta activity in all regions except 
in the parietal and occipital regions. There is also a tendency toward 
increased temporal-parietal-occipital coherence (with many values being 
statistically significant) indicating an increase in the synchronicity of the 
EEG in these areas in the second assessment that was not present in the 
first. See Table 7. The bipolar correlated data shows a significantly 
decreased beta absolute power across the entire cortex. See Table 8. 
Summarising the Neurometric results, there was an initial 
decline in alpha absolute and relative power which was fairly generalised 
across the cortex (observed in the first assessment), which was followed 
by a continuing decrease in alpha and beta activity with a concomitant 
increase in delta and theta activity (observed in the second assessment). 
These changes were present in both monopolar and bipolar studies. 
This pattern is consistent with current knowledge of 
-158-
demen ting disorders. It is an orderly progression of observations. 
Accordingly, it may be presumed that the changes observed at the initial 
Neurometric examination of this case were the earliest obtainable 
neurophysiological evidence of the disorder. Thus, Neurometric QEEG may 
have a place in the early detection of HD. 
The overall scores in the central bipolar regions (C3-CZ, C4-Cz) 
provide a multivariate indication of abnormality and may become the 
most useful single neurphysiological observation in predicting a decline in 
function (clinical diagnosis). 
A comprehensive study of the the value of Neurometrics in 
the early detection of HD is in progress. 
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APPENDIX I 
THE PEDIGREE OF THE LARGE HUNTINGTON'S DISEASE FAMILY 
OF TASMANIA 
This is an appendix to Chapter 10. It is the full pedigree of 
the Brothers family; it illustrates the relationships of 1568 individuals 
over nine generations. It occupies the next 152 pages. 
The first step in the producing this pedigree was the 
collection of the data. This is described in Chapter 4. 
The second step was to enter this data on an IBM 
compatible PC using a programme known as the Huntington' s Chorea 
Clinical Register System (V2.2). This was obtained from the Institute of 
Medical Genetics, University of Wales College of Medicine, Cardiff. 
The final step was printing, using the programme 
PLOT2000. This was also obtained from the Institute of Medical 
Genetics, University of Wales College of Medicine. This programme is 
accessed via the Huntington's Chorea Clinical Register System (V2.2) 
main menu. 
In this example, each person is identified by a generation 
-165-
and an individual number. Where known, the date of birth has also 
been added. Otherwise, conventional symbols have been employed. 
APPENDIX II 
NEUROMETRIC MAPS AND MEASURES: A CASE STUDY 
This is an appendix to Chapter 12. It is a complete 
collection of neurometric maps and measures obtained from two 
examinations of the same patient, the first on 2/12/19 8 8 and the 
second on 25/5/1990. In addition, it contains full details of a 
comparison of these sets of results. 
The hardware used was a Cadwell Spectrum 32; the 
programme, was Psychiatric Discriminants, Version 4. The comparison 
was made using the Stored T-score data analysis option. It should be 
noted that the comparison of absolute power is defined in t-test units, 
and that of relative power, power asymmetry, and coherence are 
defined in Z-score units. T-test tables and Z score tables are required 
for evaluation. 
The maps and measures are arranged in the following 
order: 
From 2/12/19 8 8 
1. Neurometric Analysis Discriminants 
2. Monopolar Raw Measures 
3. Monopolar Raw Maps 
4. Monopolar Normative Measures 
5. Monopolar Normative Maps 
6. Monopolar Z Score Measures 
-166-
7. Monopolar Z Score Maps 
8. Bipolar Raw Measures 
9. Bipolar Raw Maps 
10. Bipolar Normative Measures 
11. Bipolar Normative Maps 
12. Bipolar Z Score Measures 
13. Bipolar Z Score Maps 
14. Bipolar Multivariate Z Score Measures 
From 25/5/1990 
15. N eurometric Analysis Discriminants 
16. Monopolar Raw Measures 
17. Monopolar Raw Maps 
18. Monopolar Raw Measures 
19. Monopolar Normative Maps 
20. Monopolar Z Score Measures 
21. Monopolar Z Score Maps 
22. Bipolar Raw Measures 
23. Bipolar Raw Maps 
24. Bipolar Normative Measures 
25. Bipolar Normative Maps 
26. Bipolar Z Score Measures 
27. Bipolar Z Score Maps 
28. Bipolar Multivariate Z Score Measures 
Comparison of the results of 2/12/1990 and 25/5/1990 
29. Monopolar Independent Tscore/Diff. Zscore Measures 
30. Monopolar Independent Tscore/Diff. Zscore Maps 
31. Bipolar Independent Tscore/Diff. Zscore Measures 
32. Bipolar Independent Tscore/Diff. Zscore Maps 
33. Monopolar Correlated Tscore/Diff. Zscore Measures 
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34. Monopolar Correlated Tscore/Diff. Zscore Maps 
35. Bipolar Correlated Tscore/Diff. Zscore Measures 
36. Bipolar Correlated Tscore/Diff. Zscore Maps 
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99/99/1971 
06/12/BB 
8188 
99/99/9999 
VII 
VIII 6 
8184 
99/99/9999 
6 
8185 
99/99/9999 
Page 
724:3 
99/88/1958 
8187 
99/99/1975 
123 
8188 
99/99/1977 
8188 
99/99/1981 
06/12/BB 
rI 
.VI I 
6174 
99/99/1923 
72:30 
99/99/9999 
7281 
99/99/9999 
Page 
6176 
99/99/9999 
124 
6176 
99/99/1930 
7232 
98/88/9999 
7234 
89/99/9999 
06/12/88 
I 
II 
6177 
99/99/9999 
7285 
99/99/9999 
7286 
99/99/9989 
Page 
6178 
99/99/9999 
7237 
99/99/9899 
125 
7238 
88/89/9999 
7239 
99/99/9999 
06/12/BB 
\ 
J 
I 
II 
III 
5144 
99/99/1900 
6179 
99/99/1942 
7244 
89/99/9999 
7245 
99/99/9999 
Page 
7246 
99/99/9899 
126 
6180 
99/99/1921 
7250 
88/89/1951 
8224 
99/99/1977 
8226 
99/99/1980 
06/12/BB 
7251 
99/99/1966 
' / 
.,I I 
.,III 
7252 
99/99/1948 
7258 
99/99/1950 
8226 
99/99/1969 
Page 127 
6181 
99/99/1980 
7247 
99/88/1956 
06/12/88 
\ 
\ 
Pegs 128 06/12/BB 
I 
6182 6188 6184 6185 
99/99/9999 99/99/1928 99/99/1935 99/99/1929 
II 
7248 7249 7254 7255 
88/88/9999 88/99/9999 99/99/1947 99/99/1949 
III 
8190 8191 9192 819:3 
99/99/1978 99/99/1978 99/99/1988 99/99/1989 
Pegs 129 06/12/88 
VII 2J 6 2) [5 fE [5 
7266 7267 7258 7259 7260 7261 
99/99/9999 99/99/1967 99/88/1859 99/88/1959 89/99/1962 99/99/1966 
VIII 6 
8194 
99/99/1975 
~I 
.VII 
7262 
89/99/1969 
5145 
99/99/9999 
6186 
99/99/9999 
7263 
99/99/9999 
Page 
7264 
99/99/9899 
130 
6187 
99/99/9999 
7265 
99/99/9999 
6188 
99/99/9999 
7266 
99/99/9999 
06/12/88 
VI 
VII 
6189 
99/99/9999 
7267 
89/99/9999 
7268 
99/99/9989 
Page 
6190 
99/99/9999 
7269 
99/89/9999 
131 
7270 
98/89/9989 
7271 
99/89/9999 
06/12/88 
v 
VI 
VII 
5200 
99/99/9999 
6243 
99/99/9999 
7307 
89/88/9999 
7308 
88/99/9988 
Page 
5201 
99/99/9999 
7309 
99/99/9999 
132 
7310 
89/99/9999 
6244 
99/99/9999 
7311 
89/99/9999 
06/12/BB 
7312 
99/99/9989 
v 
VI 
5202 
99/99/1902 
6245 
99/99/9999 
6246 
99/99/9999 
Pags 
6247 
99/99/9999 
133 
5203 
99/99/9999 
6248 
99/99/9999 
6249 
99/99/9999 
06/12/BB 
6260 
99/99/9999 
v 
VI 
6261 
99/99/9999 
6 
6262 
99/99/9999 
Page 
6 
6253 
99/99/9999 
134 
5204 
99/99/1914 
6254 
99/99/9999 
6266 
99/99/9999 
06/12/88 
6266 
99/99/9999 
\/I 
VII 
6257 
99/99/9999 
6258 
99/99/9999 
7:31:3 
99/99/1978 
Page 
7:314 
99/99/1981 
136 
6259 
99/99/9999 
7315 
99/99/1984 
6260 
99/99/9999 
06/12/88 
IV 
v 
VI 
4104 
99/99/1875 
51:39 
99/99/9999 
5168 
99/99/9999 
Page 
5171 
99/99/9999 
6204 
99/99/9999 
136 
6206 
99/99/9999 
5205 
99/99/9999 
6203 
99/99/9999 
06/12/88 
r,11 
6 
5208 
89/99/9999 
4105 
99/99/1877 
5172 
99/99/9999 
Page 
5173 
99/99/9999 
137 
4108 
99/99/1880 
5174 
99/99/1890 
6206 
99/99/9999 
6207 
99/99/9999 
06/12/88 
6208 
99/99/9999 
\II 
6209 
99/99/9999 
6210 
99/99/9999 
Page 
6 
6211 
99/99/9999 
138 
6 
6212 
99/99/9999 
6213 
99/99/9999 
06/12/88 
v 
VI 
VII 
5175 
99/99/9999 
6214 
99/99/9999 
7290 
99/99/9999 
7291 
99/99/9999 
Page 
7292 
99/98/9999 
139 
6216 
99/99/9999 
7298 
99/99/9999 
06/12/88 
I 
4107 
99/99/1882 
5176 
99/99/9999 
6216 
99/99/9999 
6217 
99/99/9999 
Page 
5177 
99/99/9999 
140 
5178 
99/99/9999 
5179 
99/99/9999 
06/12/88 
5180 
99/99/9999 
IV 
v 
VI 
6 
5181 
99/99/9999 
4108 
99/99/1884 
5182 
99/99/9999 
6218 
99/99/9999 
Pegs 
6219 
99/99/9999 
141 
5188 
99/99/9999 
5184 
99/99/9999 
06/12/88 
IV 
v 
VI 
5185 
99/99/9999 
6220 
99/99/9999 
6221 
99/99/9999 
Page 
5186 
99/99/9999 
6222 
99/99/9999 
142 
6223 
99/99/9999 
4109 
99/99/1886 
5187 
99/99/1920 
6224 
99/99/1944 
06/12/BB 
./ 
I 
II 
J2f 
5188 
99/99/9998 
6226 
99/99/1947 
7294 
88/88/1979 
Page 
6226 
99/99/1949 
143 
7296 
99/99/1970 
6227 
99/99/196:3 
7296 
88/89/1980 
06/12/BB 
IV 
v 
VI 
VII 
4110 
99/99/1888 
5189 
89/99/1917 
6277 
99/99/9999 
7:322 
89/99/9999 
7328 
99/99/9998 
Page 144 
6284 6285 
99/99/9999 99/99/9999 
7824 
99/88/9999 
6286 
99/99/9999 
06/12/88 
IV 
v 
VI 
VII 
6287 
99/99/9999 
7297 
89/99/1969 
7298 
99/99/9998 
Page 
5190 
99/99/1918 
6228 
99/99/1955 
145 
6278 
99/99/9999 
4111 
99/99/1891 
5191 
89/99/1910 
06/12/88 
5192 
99/99/9999 
IV 
v 
~I 
JII 
519:3 
99/99/9999 
5194 
99/99/9999 
6288 
99/99/9999 
Page 
6289 
99/99/9999 
146 
5195 
99/99/9999 
6290 
99/99/9999 
4112 
99/99/1895 
5196 
99/99/1921 
6229 
99/99/1946 
7299 
99/89/1974 
06/12/88 
v 
VI 
VII 
6280 
99/99/1947 
7800 
99/99/9999 
Page 
6231 
99/99/1949 
7801 
99/99/1872 
147 
7802 
99/99/1974 
5197 
99/99/1923 
6282 
99/99/1954 
06/12/88 
6288 
99/99/1960 
v 
VI 
VII 
6234 
99/99/9999 
5198 
99/99/1926 
6235 
99/99/1948 
7303 
99/99/1968 
Page 
7304 
99/98/1870 
148 
6236 
99/99/1951 
7805 
99/99/1972 
7806 
99/99/1973 
06/12/BB 
6237 
99/99/1953 
v 
VI 6 
6238 
99/99/1964 
5199 
99/99/1933 
6289 
99/99/1963 
Page 
6240 
99/99/1965 
149 
6241 
99/99/1970 
6242 
99/99/1972 
06/12/88 
III 
IV 
8012 
1/ 7/9999 
4095 
99/99/9999 
4096 
99/99/9999 
Page 
8013 
24/ 8/1853 
4080 
99/99/1875 
150 
4081 
99/99/9999 
8014 
99/99/9999 
4082 
99/99/1878 
06/12/88 
4088 
99/99/1879 
IV /Qi 
4084 
99/99/1884 
4085 
99/99/18815 
Page 
6 
4086 
99/99/1887 
161 
CS 
4087 
99/99/1890 
4088 
99/99/1892 
06/12/88 
IV 
v 
VI 
4089 
99/99/1893 
5087 
99/99/9999 
6070 
99/99/9999 
6071 
99/99/9999 
Page 
6072 
99/99/9999 
162 
6077 
99/99/9999 
5088 
99/99/9999 
6078 
99/99/9999 
06/12/88 
6079 
99/99/9999 
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Patient Clinical Record 
12/2/88 
Neurometric Analysis (QEEG) Discriminants 
Classification functions in this program were derived fran 
groups of patients who met specific criteria for group 
membership. 
Neurometric classifications are statistical in nature and 
serve only as an adjunct to the other clinical results 
used to evaluate the patient. 
'This patient's discriminant scores lie outside of the nonnal 
limits ex:i;:;ected for an individual of this age. 
,.e: GK F 
ie: 27. 4 yrs 
Analyzed: 05/30/90 Recorded: 12/02/88 
# Epochs: 38 
~opolar Raw Measures 
lbsolute A 
Power 6 
<uU2 ) ex 
13 
T 
elative A 
Power 6 (;..:) ex 
13 
f ower A 
":flllflletry 6 
<:.-:) ex 
13 
lherence A 
(%) 6 
ex 
13 
lbsolute A 
Power 6 {uU2 ) ex 
13 
T 
.elative A 
f ower 6 
<:.-:) ex 
13 
f ower A 
1:1111111etry 6 
<:.-:) ex 
13 
rtierence A 
(%) 6 
ex 
13 
Fpl Fp2 F7 re F3 F4 C3 C4 Fpz Fz Cz 
---- ----
7.8 7.4 5.2 6.1 13.5 11.1 16.1 12.0 7.9 15.2 20.4 
5.7 5.3 4.4 3.9 8.1 7.2 7.0 5.9 5.8 8.8 8.6 
...... 1. 5 
1.6 ----- - - -2.7 3.3 3.0 2 8 3.0 3.6 2.6 3.4 2.6 3.1 2.9 
17.8 17.6 14.1 14.3 26.5 23.8 27.4 22.8 18.1 29.1 33.8 
43. 7 42. 1 36. 9 42. 4 .1B!lJ 46. 4 •1=8:1 •1'*1 43. 9 a."t• l;f!lSI 
32.0 29.9 31.1 27.4 30.5 30.0 25.7 25.7 32.2 30.1 25.4 
__ •l!l•l Wl!lR:l =-m llB] 11m mm mJ1J miE ~
18.6 21.1 19.3 11.2 15.1 9.5 15.0 14.5 10.6 8.6 
2. 5 - - . -_., .. , l".0 
4.0 
0.8 
-10.6 
T3 
88.6 
89.9 
86.2 
74.9 
---
T4 
5.6 
-0.4 
3.5 
28.0 
41.1 
42.8 
31.1 
T5 T6 
---- ----
6.1 
-2.3 
-9.3 
88.1 
83.1 
77.4 
66.8 
P3 P4 
---- ----
•llEl 9.2 
3.7 
-13.7 
87.7 
78.9 
61. 3 
57.6 
01 02 Pz Oz 
---- ----
4.4 
2.8 
4.1 5.4 3.0 13.2 10.9 7.1 5.3 16.6 5.7 
-3.1 11. 6 URllilRilllRil 13.2 9.7 7.3 22.1 19.6 12.7 10.5 27.9 11.0 
38.1 30. 9 a.1:m 40. 0 ••=1 ... ,.. •-i.-w:a •1!la:1 •-s:E a.1'•1 
24.2 18.0 24.6 23.8 25.2 26.0 23.2 23.4 26.1 24.7 
Wl!la~ 11. 9 ... Rm MMCJ mJll WIW! Wt.&j •W •tR!lJ 
27.0 39.2 10.8 -z0.'b 8.7 11.0 10.1 13.2 8.4 12.0 
4.1 29.4 9.7 14.1 
8.4 15.8 4.4 9.3 
-11.2 -14.2 -2.0 3.8 
-24.4 -17.6 -5.6 -3.6 
• 
55.2 92.9 93.6 
30.1 86.1 88.3 
11. 9 
• 
61. 2 75.5 
7.3 69.8 75.1 
Monopolar Raw Maps 
Delta 
Absolute 
Power 
C0 - 60 uva 
Coherence 
Na111e: GK F 
Age: 27.4 ~rs 
Theta Alpha 
Anal~aed: 05/30/90 
Recorded: 12/02/88 
Beta 1 
-te: GK F Analyzed: 05/30/90 Recorded: 12/02/88 
.: 27.4 yrs # Epochs: 38 
1opolar Norrraative Measures 
Fpl Fp2 F7 F8 F3 F4 C3 C4 Fpz Fz Cz 
---- ---~solute A 10.0 9.7 6.5 6.0 10.8 10.3 10.5 10.7 9.8 12.8 15.8 )ow er 6 6.8 6.6 5.0 4.7 9.8 9.4 9.9 10.0 6.7 12.6 15.6 
:uuz) ()( 8.8 8.6 6.6 6.4 12.4 12.1 14.5 15.6 8.7 15.2 20.7 
13 4.5 4.3 3.6 3.4 5.9 5.9 6.3 6.4 4.4 6.5 8.2 
';:!lat ive 6 32.1 32.0 28.7 28.3 26.2 26.0 24.3 24.1 32.1 25.9 25.1 )ow er 6 21.3 21. 4 22.0 21. 8 24.1 23.8 22.6 22.3 21. 4 25.6 24.5 (%) ()( 28.5 28.8 29.9 31. 0 31. 3 31. 5 34.7 35.4 28.6 31. 7 33.4 
13 14.3 14.1 15.9 15.9 14.6 15.1 14.5 14.1 14.2 12.9 12.9 
)ower 6 1. 7 3.3 2.1 -1. 9 
~rrarraetry 6 1. 4 3.3 2.3 -1. 7 
(%) ()( 0.9 1.1 1. 3 -3.2 
13 1. 8 2.6 0.3 -1. 0 
')erence 6 87.4 29.1 83.6 82.2 
(%) 6 86.4 29.8 83.0 76.6 
()( 92.7 52.8 88.2 68.0 
13 78.6 28.9 73.1 54.6 
T3 T4 T5 T6 P3 P4 01 02 Pz Oz 
--- ---- ---- ---- ---- ---- ---- ---- ---- ----
,solute 6 4.8 4.3 7.2 6.9 11. 4 11. 2 9.5 9.7 14.0 9.6 )ower 6 4.2 3.7 6.5 6.1 10.0 9.8 8.2 8.2 12.7 8.2 
II( uU2 ) ()( 6.3 6.1 17.0 20.5 25.6 27.0 33.2 38.1 31. 7 35.6 
13 4.0 3.5 6.0 6.1 8.0 8.1 8.1 8.6 8.8 8.3 
•?lative 6 23.6 22.3 18.6 16.6 19.4 18.6 15.2 13.9 19.4 14.5 )ow er 6 20.5 19.1 16.4 14.1 16.9 16.2 13.0 12.0 17.3 12.5 (%) ()( 32.1 32.5 45.4 50.5 45.5 47.2 54.9 57.4 46.4 56.1 
13 20.0 18.5 15.3 14.5 13.4 13.2 12.8 12.4 12.2 12.6 
Power 6 5.2 1. 7 0.4 -0.4 
~rrarraetry 6 5.8 3.4 0.7 -0.5 
(%) ()( 2.0 -8.8 -3.5 -6.9 
13 6.7 -1. 0 -0.7 -2.7 
lherence 6 25.1 55.2 85.7 86.7 
(%) 6 13.5 32.4 78.4 81.1 
DC 18.0 29.6 70.3 77.5 
13 10.4 17.3 61. 4 70.1 
Monopolar NorNative Maps NaNe: GK F 
Age: 27.4 ~rs 
Absolute 
Po.,er 
ce - 60 uva 
Relative 
Power 
Power 
As!::IN"et r!:f 
Coherence 
Delta Theta Alpha 
Anal~zed: 05/30/90 
Recorded: 12/02/88 
Beta 1 
:'.:e: GK F 
t?: 27. 4 yrs 
1opolar Z Score Measures 
Fpl Fp2 F7 F8 
Analyzed: 05/30/90 Recorded: 12/02/88 
# Epochs: 38 
F3 F4 C3 C4 Fpz Fz Cz 
)Solute A -0.47 -0.52 -0.51 0.03 0.58 0.16 1.05 0.26 -0.42 0.42 0.61 
>ower 9 -0.36 -0.48 -0.29 -0.35 -0.45 -0.62 -0.74 -1.14 -0.29 -0.80 -1.33 
~ -1.93 -1.80 -2.42 -2.32 -2.73 -2.89 -2.13 -2.55 -3.01 
6 -1.11 -0.61 -0.36 -0.39 -1.31 -0.93 -1.56 -1.14 -1.12 -1.36 -1.82 
~lative A 0.91 0.82 0.79 1.31~ 1.80 0.94 2.23 2.79 
>ower 9 1.71 1.38 1.48 1.04 0.93 0.92 0.44 0.51 1.73 0.63 0.14 
~ 
6 
)ow er A 
:1111111et ry 9 
~ 
6 
~erence A 
9 
~ 
6 
-2.12 -2.14 -2.14 -2.27 -2.84 -2.62 -3.43 -3.32 -2.13 -2.90 -3.31 
0.11 0.78 0.80 0.57 -0.67 0. 00 -1. 03 0.16 0.06 -0.51 -0.98 
0.11 -0.65 1. 05 ~ 0.40 0.14 0.52 1. 44 
-0.02 -0.10 -0.53 0.74 
-1.53 0.06 -1.22 -1.41 
0.18 -0.06 0.85 1. 02 
0.67 0.53 0.02 0.37 
-1. 09 -0.40 -1.33 -0.46 
-0.32 0.16 -0.58 0.25 
T3 T4 T5 T6 P3 P4 01 02 Pz Oz 
---- ---- ---- ---- ---- ---- ---- ----
•!lative A 1. 48 0. 66IEBEI) 1. 95 2.89 2.64 2.76 2.57 2.67 2.61 
'Power 9 0.60 -0.12 1.07 1.30 0.98 1.19 1.21 1.36 1.01 1.41 
~ WC@J -1. 69 In 
6 0.73 1.51 -0.74 0.76 -0.91 -0---:-40 -0.47 0.11 -0.80 -0.10 
-3.10 -2.42 -3.41 -3.28 -2.86 -2.84 -3.38 -2.95 
!Power A -0.03 1. 65 1. 05 1. 82 
:fl'lll'letry 9 0.07 0.68 0.43 1.19 
~ -0.32 -0.27 0.11 0.73 
6 -0.73 -1.04 -0.45 -0.07 
lherence A 
.. 
-0.00 1. 38 1. 29 
9 -0.15 1.07 1. 09 
~ -0.59 
-
-0.64 -0.18 
6 -0.55 0.80 0.55 
Monopolar Z Score Maps 
Delta 
Absolute 
Po..,er 
Relative 
Power 
Power 
As!:l""•t r!:I 
Coherence 
Nallie: GK F 
Age: 27. 4 !:lrs 
Theta Alpha 
Anal!:IZ•d: 05/38/90 
Recorded: 12/02/88 
Beta 3.1 
1. 9 
-1.9 
-3.1 
!lll!!l1' 1lum 
H!H!!1 
1mm: 
·~e: GX F 
.-.: 27. 4 yrs 
Analyzed: 05/30/90 Recorded: 12/02/88 
I Epochs: 38 
iepolar Raw Measures 
Central Te111poral Parietal Frontal 
Occipital Te111poral 
C3/Cz C4/Cz T3/T5 T4/T6 P3/0l P4/02 F7/T3 F8/T· 
llbsolute 
Fower 
ll(uU2 ) 
l:J. 
8 
(J( 
13 
1. 7 
1. 4 
0.6 
0.9 
3.3 
1. 6 
0.6 
1. 3 
•al Absolute Power 
•al Power Asy111111etry 
.. 
-20.4 
6.8 
-.lative 
IPower 
(%) 
lfower 
.y111111etry 
(%) 
l:J. 
8 
(J( 
13 
t:J.+8 
Co111hination 
l:J. 
8 
(J( 
13 
Co111hination 
37.9 •IE•I 30.2 23.3 
•t .. n ... 19.5 18.9 
68.1 
• 0.7 
;w41 
-7.6 
-3.2 
-19.0 
1. 1 
~erence l:J. 28.3 
c:.-:> e a.a 
(J( 13.3 
13 22.7 
Co111hination 0.8 
.erall 
2.4 4.8 
1. 6 2.1 
0.8 1. 3 
3.0 5.1 
7.8 13.3 
-26.3 
30.6 -~-1 20.0 
•li.•=l 38.5 
50.7 
0.9 
fiCJI:] 
-14.8 
-22.2 
-26.0 
0.8 
15.7 
2.3 2.5 2.0 2. 
1. 5 1. 6 1. 5 1. ~ 
0.8 0.9 0.9 1. 
0.8 0.9 3.0 4. 
5.4 5.9 7.5 9.' 
-4.3 -12.6 
···~ •f'.ai.J 27.1 23.: 28.2 27.3 20.4 16. ~ 
•11191 .1--.1 12.1 11. :i 
15.5 15.6 40.4 ~ 
•ii.Bi.] •*•l 47.4 39 .. 0.9 0.9 0.6 0.lt 
-4.6 -5.2 
-2.6 -1. 3 
-6.4 -11. 7 
-4.5 -21.5 
-1. 4 0.1 
78.1 39.0 
70.4 40.7 
65.2 22.8 
42.5 .. 
0.6 0.8 
2.4 2.2 
Bipolar Raw Maps 
Relative 
Power 
Power 
As~uo1etrl:I 
Coherence 
Delta 
NaNe: GJ( F 
Age: 27.4 yrs 
Theta Alpha 
Rnal~sed: 05/30/90 
Recorded: 12/02/88 
Beta 1 
'1e: GK F Analyzed: 05/30/90 Recorded: 12/02/88 
I?: 27.4 yrs # Epochs: 38 
~o 1 ar Nor111a t i ve Measures 
Central Te111poral Parietal Frontal 
Occipital Te111poral 
C3/Cz C4/Cz T3/T5 T4/T6 P3/0l P4/02 F7/T3 F8/T 
----- ----- ----- ----- ----- ----- ----- ----· 
;al Absolute Power 15.1 15.8 26.3 26.3 23.4 25.1 14.8 14. )I 
.al Power Asy111111etry -2.7 0.2 -3.3 2.2 
ielative ll 19.2 18.2 14.5 13.2 11. 7 11. 6 24.6 24. ~ )ow er 8 22.4 21. 8 14.0 12.3 13.2 13.0 17.5 16. ~ (%) DC 34.1 35.1 48.9 53.0 56.5 57.0 29.6 31. ~ 
6 20.3 20.7 17.6 16.7 14.6 14.1 24.2 23." 
ll+8 43.1 41. 3 29.6 26.4 26.0 25.8 43.3 41. ~ 
Co111bination 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0. ~ 
>ower ll -0.5 2.6 -3.l 0.9 
·~111111et ry 8 -1. 9 5.3 -1. 9 5.1 (;..:) DC -3.6 -3.0 -4.1 0.6 
6 -4.2 2.2 -2.1 4.2 
Co111bination 0.4 0.4 0.4 0.4 
-.ere nee ll 31. 6 53.0 62.3 43.2 
(;..:) 8 29.5 44.2 66.1 38.7 
[)( 19.3 56.6 74.2 40.3 
6 15.0 25.9 54.1 19.4 
Co111bination 0.5 0.5 0.4 0.4 
1!rall 2.1 2.1 2.1 2.0 
Bipolar 2 Score Maps 
Delta 
Relative 
Power 
Power 
As~1u•etr~ 
Coherence 
NaNe: GK F 
Age: 27.4 ~rs 
Theta Alpha 
Anal~aed: 05/30/90 
Recorded: 12/92/88 
Beta 3.1 
1. 9 
-1.9 
HiHiI 
-3.1 ~m1 
•e: GK F 
-.: 27. 4 yrs 
•olar Z Score Measures 
~al Absolute Power 
~al Power Asy~~etry 
•dative A 
'"-ower e 
IX 
f3 
A+8 
Co~bination 
)ower A 
~~~etry e 
ex 
f3 
Co~bination 
'le:rence A 
e 
ex 
f3 
Co~bination 
Analyzed: 05/30/90 Reco:rded: 12/02/88 
I Epochs: 38 
Cent:ral Te~po:ral Pa:rietal F:rontal 
Occipital Te~po:ral 
C3/Cz C4/Cz T3/T5 T4/T6 P3(01 P4/02 F7/T3 F8/T4 
----- ----- ----- ----- ----- ----- ----- -----
"'' -1.47 -1.62 -0.86 -1.76 -1.78 -1.31 -0.7~ 
-1.61 -1.58 -0.06 -1.11 
--0.58 0.03 
-1.24 
1. 42 
-0.18 
-1.88 
-0.55 
0.60 
0.96 
1. 48 R«§t~ W WCl:J 
0.86 0.55 1.68 1.63 
1.54 1.61 0.11 0.19 
1.39 1.71 ~~..fill 
1. 37 ••• 1. 42 1. 44 
R•B 
-1.21 
-0.92 
-1.38 
0.80 
0.07 
-0.36 
-1. 81 
M**1 
1. 92 
-0.08 
-0.05 
-0.12 
-0.15 
-4.22 
1. 22 
0.47 
-0.67 
-1.12 
0.38 
0.74 
0.26 -0.1)1 
0.55 0.0)1 
-1. 82 -1. 9'-
1. 34 ~ 
0. 34 -0. r~ 
0. 78 1. 2~ 
-0.43 
-0.56 
-0.69 
-1. 07 
-0.75 
-0.22 
0.17 
-1.20 
.§IC] 
1. 00 
0.52 
Bipolar Nor ... ative Maps 
Delta 
Relative 
Potlfer 
Power 
As~.-111etr~ 
Coherence 
Na111e: GK F 
Age: 27.4 ~rs 
Theta Alpha 
Anal~aed: 05/30/90 
Recorded: 12/02/99 
Beta 1 
m:m 
::::::t 
Hllii!1 
ll~lll 
m~~ 
-llmm; rnm: 
ie: GK F 
· 27.4 yrs 
Analyzed: 05/30/90 Recorded: 12/02/88 
# Epochs: 38 
·olar Multivariate Z score Measures 
:al Absolute Power 
~al Power As~~~etry 
~lative )ower 
/j. 
6 
DC 
13 /j.+6 
Co~hination 
.bwer /j. 
·J~~etry 6 
DC 
13 
Co~hination 
~erence -ll 
6 
DC 
13 
Co~hination 
L HEM R HEM BACK FRONT ALL 
1.46 0.92 1.44 0.81 1.31 
0.69 0.99 0.92 
1.26 llllll:i 1.86 
0.11 0.50 1.09 
1.28 1.95 1.67 
0.66 0.93 -2.51 
1.58 1.88 ~
1.89 1.54 1.38 
1. 35 
-0.88 
-2.93 
0.29 
0.84 
1.32~ 
-0.96 0.40 
1. 51 1. 50 
0.38 0.31 
0. 64 1. 91 
1. 12 -1. 00 
1.15 
0.36 
0.16 
0.89 
0.21 
1. 65 
-0.43 
-0.81 
0.60 
0.55 
0~30 -1.79 -0.55 
0.97 -1.49 0.35 
-0.21 1.13 0.77 
0.27 ~ llllllml 
0.73 1.72 1.76 
1.45 1.77 0.67 
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Patient Clinical Record 
05/23/90 
Neurornetric Analysis (QEEG) Discriminants 
Classification functions in this program were derived from 
groups of patients who met specific criteria for group 
membership. 
Neurornetric classifications are statistical in nature and 
serve only as an adjunct to the other clinical results 
used to evaluate the patient. 
'Ihis patient's discriminant scores lie outside of the normal 
limits expected for an individual of this age. 
•e: GK2 F Analyzed: 06/12/90 Recorded: 05/23/90 
mt: 28.9 yrs # Epochs: 38 Site Id: RHH 
~opolar Raw Measures 
_:4solute A 
ow er 6 
CuU2 ) DC 
f3 
T 
-tlative A 
:bwer 6 
-(%) DC 
f3 
jower A 
~111rriet ry 6 
(%) DC 
f3 
'lerence A 
(%) 6 
DC 
f3 
·bsolute A 
?ower 6 
(uU2 ) DC 
f3 
T 
-elative A 
·Power 6 
(%) DC 
f3 
If ower A 
:1rrirriet ry 6 
(%) DC 
f3 
lflerence A 
(%) 6 
()( 
f3 
Fpl Fp2 F7 re F3 F4 C3 C4 Fpz Fz Cz 
14. 3 12. 6 ..... ,., 9. 2 •.J•J 20. 7 •!§St 23. 9 15. 6 R'..fWJ &Wl 
5.5 5.3 5.6 3.8 8.9 7.4 9.7 7.9 5.5 9.2 11.0 
11 .................. . 2.8 2.7 1.9 2.4 2.7 llll!!EJ 2.4 2.0 llll!!EJ 
22.5 22.0 24.6 16.2 39.9 32.3 43.7 35.9 24.6 42.3 50.5 
1ss1 •1'•1 pria~ •1'«riJ Qlli l;IW!il QSt IWi UN U:N ltiriK§J 
24.5 24.0 22.9 23.5 22.3 22.8 22.1 21.9 22.6 21.8 21.8 
............... , .... ~ ... --
6.8 12.5 11.0 11.9 lllt!ll 8.3 ~ 6.7 8.3 .. llllJ!ll 
6.3 23.6 13.2 11.9 
2.2 19.4 9.3 10.4 
-6.2 3.3 0.9 -0.3 
11'..f:Ki 16. 7 -5. 7 -9. 7 
.• , 
93.5 
85.9 
63.8 
T3 T4 T5 
69.3 
57.3 
28.9 
20.9 
T6 
E~B§l El•l 88.4 86.9 
78.4 75.5 
62.8 70.9 
P3 P4 01 02 
---- ---- ---- ---- ---- ----
Pz Oz 
.,. 
4.8 
.. 
2.3 21. 9 7.6 15.5 13.1 26.2 25.3 ... §] 23.7 26.1 18.2 2.9 4.9 4.2 8.0 7.5 7.0 7.3 7.5 5.8 1.6·------------3.1 2.~.. 2.5 1111!11! 2.9 ~ 3.0 15.2 23.6 22.4 38.2 37.5 40.6 36.6 38.3 29.7 
l:J§•4 49. 8 Q."W:l •1=•l U=•4 QR! ltiB! II•• Q:K§l l;tm 
22.1 19.0 20.6 18.5 21.0 20.1 17.2 20.0 19.5 19.4 
... 10.6 ... (§·]--fi:SJ .] .... ·•1 
10.6 20.6 7.2 12.9 lllEll1 6.6 5.5 7.9 6.5 10.0 
27.5 8.6 1.8 10.2 
25.3 8.0 3.1 -2.4 
-5.1 -20.9 -6.0 -6.2 
-15.0 -26.0 -11.6 -12.6 
63.1 
42.9 
5.9 
5.0 
BI 51. 0 
46.7 • 83.2 l:JRI 
93.5 
W:JCN 
92.4 
•t•l 
Monopolar Raw Maps 
Delta 
Absolute 
Po.,er 
<9 - 69 uva 
Relative 
Power 
Coherence 
Na111e: GKZ F 
Age : 28 . 9 !:.t rs 
Theta Alpha 
Rnal~aed: 06/12/90 
Recorded: 95/23/99 
Beta 1 
~e: G:K2 F Analyzed: 06/12/90 Recorded: 05/23/90 
t: 28.9 yrs I Epochs: 38 Site Id: RHH 
~opolar Nor~ative Measures 
Fpl Fp2 F7 r0 F3 F4 C3 C4 Fpz Fz Cz 
-- ---- ---- ----
___ .... 
---- ----
_ ...... __ 
---- ---- ----
·~solute ll 9.9 9.6 6.4 6.0 10.6 10.2 10.3 10.6 9.7 12.6 15.5 
•lower 6 6.7 6.6 5.0 4.7 9.7 9.3 9.7 9.9 6.6 12.4 15.3 
:uuz) 0: 8.9 8.7 6.7 6.6 12.5 12.2 14.7 15.6 8.8 15.3 20.7 
13 4.6 4.5 3.7 3.5 6.1 6.0 6.5 6.6 4.5 6.6 8.4 
~lative A 31. 8 31. 7 28.2 28.0 25.8 25.7 23.8 23.8 31. 7 25.6 24.7 
-owe:r 6 21.1 21.1 21. 7 21. 5 23.7 23.4 22.2 22.0 21.1 25.2 24.1 (%) 0: 28.7 28.9 30.2 31.1 31. 6 31. 8 34.8 35.5 28.8 31. 9 33.5 
13 14.6 14.4 16.3 16.3 15.0 15.4 14.9 14.6 14.5 13.2 13.4 
"'ower A 1. 6 2.9 2.0 -1. 8 
~~~et:ry 6 1. 4 3.1 2.3 -1. 5 
(%) 0: 0.9 1. 1 1. 3 -Z.9 
13 1. 7 2.5 0.4 -0.9 
"Jerence A 87.4 28.8 83.5 82.2 
(%) 6 86.4 29.7 83.0 76.6 
0: 92.7 52.4 88.2 68.1 
13 78.5 29.1 73.2 54.4 
T3 T4 T5 T6 P3 P4 01 02 Pz Oz 
---- ---- ---- ---- ---- ---- ---- ---- --)Solute A 4.7 4.2 7.1 6.8 11. 2 11. 0 9.3 9.4 13.7 9.4 )owe:r 6 4.1 3.7 6.4 6.0 9.8 9.7 8.2 8.1 12.4 8.2 (uU2 ) 0: 6.5 6.2 17.1 20.3 25.5 26.8 32.8 37.3 31. 3 34.9 
13 4.1 3.6 6.2 6.2 8.2 8.3 8.2 8.6 9.0 8.4 
1ilative A 23.1 22.0 18.2 16.4 19.1 18.4 15.0 13.8 19.2 14.4 
:>ower 6 20.2 18.8 16.2 14.1 16.7 16.0 13.0 12.1 17.2 12.5 (%) 0: 32.4 32.8 45.5 50.3 45.4 47.0 54.6 57.1 46.2 55.9 
13 20.4 18.9 15.7 14.9 13.9 13.6 13.2 12.7 12.6 13.0 
·?ower A 4.9 1. 8 0.4 -0.3 
:J~~et:ry 6 5.8 3.8 0.8 -0.2 (%) 0: 2.3 -7.9 -3.3 -6.4 
13 6.7 -0.4 -0.7 -2.3 
lt)erence A 25.0 55.4 85.7 86.8 (%) 6 13.7 32.9 78.5 81. 2 
0: 18.1 29.8 70.4 77.6 
13 10.4 17.6 61.4 70.3 
Monopolar Nor11tative Maps 
Delta 
Absolute 
Power 
ce - 60 uva 
Relative 
Power 
Coherence 
Nawe: GK2 F 
Age: 28. 9 !:lrS 
Theta Alpha 
Anal!:lsed: 06/lZ/90 
Recorded: 05/23/90 
Beta 1 
..ie: GK2 F 
- : 28. 9 yrs 
Analyzed: 06/12/90 Recorded: 05/23/90 
# Epochs: 38 Site Id: RHH 
1opolar Z Score Measures 
·•solute 6 
·•ower e 
()( 
13 
•tlative 6 
·~ower e 
()( 
13 
~ower 6 
Jllllllet ry e 
()( 
13 
i41erence 6 
)ower 
)ower 
e 
()( 
13 
6 
:flllllletry e 
()( 
13 
;nerence 6 
e 
()( 
13 
Fpl Fp2 F7 FS F3 F4 C3 C4 Fpz Fz Cz 
2. 05 1. 981 0.69 0.54illlm 0.93W 1.73®«*3 1.93 0.91 
-0.41 -0.45 0.29 -0.41 -0.19 -0.52 -0.01 -0.48 -0.37 -0.65 -0.73 
. . . 
. . 
2.43 2.01 2.91 2.58 3.60 3.27 3.74 3.50 2.47 3.68 3.61! 
0.60 0.52 0.22 0.40 -0.22 -0.10 -0.01 -0.01 0.27 -0.52 -0.35 
: : § • 
0.63 1. 26 1. 49 1. 84 
0.12 1. 02 0.97 1. 57 
-1. 29 0.15 -0.05 0.28 
r:R:@ 0.89 -0.77 -0.97 
~ 1. 62 IED ~ 
1. 63 1.16 1. 09 1. 94 
-1.12 -1. 04 -1. 23 0.56 
-1. 20 -0.68 -0.95 1. 40 
T3 T4 T5 T6 P3 P4 01 02 Pz Oz 
---- ---- ---- ---- ---- ---- ---- ----
3.66 3.08 3.54 3.44 3.75 3.36 3.23 3.13 
-3.60 -3.71 -3.56 -3.37 -3.15 
0.59 0.39 0.16 1. 31 
0.52 0.23 0.27 -0.26 
-0.18 -0.65 -0.21 0.02 
-0.50 -1. 63 -1. 01 -0.86 
1. 75 
- -
1. 25 
1. 62 ~
-1.58 0.93 1. 09 1. 83 
-1.12 1. 77 ~ ~
Monopolar 
Absole.ite 
Power 
Relative 
Power 
Coherence 
Score Maps 
Delta 
Na111e · 
Age: 
GKZ F 
29.9 "I'S 
Theta 
Rnal!rlZed : 
Recorded : 
Alpha Beta 
06/lZ/98 
95/23/99 
3.1 
1.9 
-1.9 
-3.1 
"le: GJ<2 F 
tt: 28. 9 Yl"S 
~olal" Raw Measul"es 
.. solute 
·)owe I" 
CuU2 ) 
ll 
6 
DC 
13 
~al Absolute Powel" 
tal Powel" Asy~111etry 
itlative )owe I" 
(%) 
?owel" 
:l~~etl"y 
(%) 
lherence 
(%) 
ierall 
ll 
6 
DC 
13 
ll+6 
Co~bination 
ll 
6 
DC 
13 
Co~bination 
ll 
6 
DC 
13 
Co111bination 
Analyzed: 06/12/90 Recol"ded: 05/23/90 
I Epochs: 38 Site Id: RHH 
Central Te111poral Parietal Frontal 
Occipital Te111poral 
C3/Cz C4/Cz T3/T5 T4/T6 P3/01 P4/02 F7/T3 FS/T• 
----- ----- ----- ----- ----- ----- ----- ----· 
1. 9 3.3 
1. 1 1. 3 
0.4 0.4 
0.5 0.6 
.. 5.6 
-17.5 
lltB:l 
28.9 
.... 
13.6 
.,.~ 
•1=•=l 23.0 
1. 0 
.. 
10.8 
II 
lif.fSI 
-6.1 
-4.2 
-6.0 
0.8 
34.5 
-'tl:l 12.6 
24.7 
1111] 
.. 
2.5 
1. 4 
1. 1 
2.0 
7.0 
-15.1 
35.0 
20.5 
•tw•4 
28.8 
55.5 
0.7 
-22.6 
-1. 0 
-11. 4 
-15.6 
0.6 
54.2 
40.1 
34.2 
12.5 
0.5 
2.4 
3.9 
1. 5 
1. 4 
2.8 
9.5 
5.3 1. 4 
1. 3 0.9 
0.4 0.5 
0.5 0.6 
7~ 
11191 
25.9 
•1•~1 
18.8 
DBI 
0.9 
•-i:•• 18.9 
-2.1 
-10.5 
... 
II . 41. 4 
1. 0 
.. 
1. 9 
1. 5 
0.9 
3.0 
7.2 
-0.7 
26.0 
20.4 
11. 7 
41. 8 
46.4 
0.7 
1. 4 
6.8 
-10.7 
-2.3 
-0.1 
32.0 
43.9 
17.4 
1.. 
1. ~ 
1.: 
3. ;. 
7 .. 
25 ... 
17 ... 
14.: 
43. 
42.~ 
0 ... 
-•4 1.1 
2.6 
Bipolar Kaw Maps 
Relative 
Power 
Power 
Asy .... etry 
Coherence 
Delta 
Na111e: GKZ F 
Age: 28.9 !:fl'S 
Theta Alpha 
Anal~zed : 86/lZ/98 
Recorded: 05/23/96 
Beta 1 
mm11 
111111! 
ll~!~i 
-ui!!~I 
•e: Gl<2 F Analyzed: 06/12/90 Recorded: 05/23/90 
. 28.9 yrs I Epochs: 38 Site Id: RHH 
•olar Nortr1ative Measures 
Central Tetr1poral Parietal Frontal 
Occipital Te111poral 
C3/Cz C4/Cz T3/T5 T4/T6 P3/01 P4/02 F7/T3 F8/T• 
----- ----- ----- ----- ----- ----- ----- ----· 
;al Absolute Power 15.1 15.8 26.3 26.3 23.4 25.1 14.8 14.: 
~al Power Asytr1111etry -2.7 0.2 -3.3 2.2 
1ative 6 18.8 17.9 14.2 13.0 11. 6 11. 5 23.9 23. ~ 
.ower 6 21. 9 21. 3 13.8 12.2 13.2 12.9 17.3 16 .• (%) [)( 34.0 34.9 48.8 52.7 56.0 56.6 29.8 31.91 
13 21. 0 21.5 18.0 17.1 15.1 14.5 24.7 23. ~· 
t:t.+9 42.3 40.5 29.2 26.1 25.8 25.6 42.4 4L: 
Co111bination 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.: 
bwer 6 -0.5 2.6 -3.1 0.9 
J111111et ry 6 -1. 9 5.3 -1. 9 5.1 (%) [)( 
-3.6 -3.0 -4.1 0.6 
13 -4.2 2.2 -2.1 4.2 
Co111bination 0.4 0.4 0.4 0.4 
·l'lerence A 30.6 52.6 62.2 42.6 
(%) 6 28.4 44.1 66.0 38.4 
[)( 19.3 56.3 73.9 40.1 
13 14.8 25.9 53.7 19.4 
Co111bination 0.5 0.5 0.4 0.4 
•!rall 2.1 2.1 2.1 2.0 
Bipolar Nor .. ative Maps 
Delta 
Relative 
Power 
Power 
Asy1u•etry 
Coherence 
Na .. e: GKZ F 
Age: 28.9 ~rs 
Theta Alpha 
Analysed : B~/lZ/~B 
Recorded: 05/23/90 
Beta 1 
!l:,1111 
•1e: GK2 F 
- : 28. 9 yrs 
•olar Z Score Measures 
.al Absolute Power 
~al Power Asy111111etry 
-tlative A 
·~ower 6 
0: 
13 
A+6 
Co111hination 
-+ower ll 
~111111et ry 6 
0: 
13 
Co111hination 
-.erence ll 
6 
0: 
13 
Co111hination 
•trall 
Analyzed: 06/12/90 Recorded: 05/23/90 
I Epochs: 38 Site Id: RHH 
Central Te111poral Parietal Frontal 
Occipital Te111poral 
C3/Cz C4/Cz T3/T5 T4/T6 P3/0l P4/02 F7/T3 F8/T~ 
----- ----- ----- ----- ----- ----- ----- -----
~ -1.82 
-1. 33 
.am 
-0.43 
-0.04 
-0.15 
0.95 
0.19 
•1! 
-0.62 
0.74 
~
mnJ 
-1.76 -1.29 
-0.90 
1.02 ••s 
0.94 0.51 
Wi;J;, R•t:l 
0.87 0.98 -1. 47 
1.73--0.94 §§ ~ 
-1.45 
-i:•I! 
-0.38 1. 38 
-0.39 0.11 
-0.86 -0.53 
0.45 ••ti 
0.13 II -0.42 -1.25 
-1.52 -1. 20 
0.09 1. 55 
0.91 
-1. 38 -1. 2~ 
-0.22 
0.22 
0.62 
0. H· 
0.3)1 
-1. 89 
1. 39 
0.33 
0.89 
-1. 5r~ 
1. 5~ 
0. H 
0. 7~ 
0.03 
0.15 
-0.63 
-0.26 
-1.39 
1. 38 
Bipolar Z Score Maps 
Delta 
Relative 
Power 
Po'l!er 
As!:J""et r!:J 
Coherence 
Na .. e: 
Age: 
GKZ F 
28.9 !:JrS 
Theta 
Anal~sed: 
Recorded: 
Alpha Beta 
06/lZ/90 
05/23/90 
3.1 
-1 . 9 
-3.1 
1e: Gl<2 F Analyzed: 06/12/90 Recorded: 05/23/90 
. 28.9 Yl"S I Epochs: 38 Site Id: RHH 
·olar Multival"iate Z score Measures 
L HEM R HEM BACK FRONT ALL 
----- ----- ----- ----- -----
.al Absolute Powel' 1. 50 1.52 1. 66 1.15 1. 62 
al Powel' Asy111111etl"Y 1. 72 -0.21 1. 48 
lative ll 1.56 mlllD 
•owe:r e -1.10 1.16 
[)( 1.191111 13 0.03 
ll+6 0.97 : 
Co111hination -0.07 0.50 
.. 'owe:r ll 1. 94 0.55 ~ 
1111111et ry e 0.51 -1.67 -0.34 
[)( 
-3.05 -0.52 -1. 76 
13 -1. 05 -0.00 -0.82 
Col'lhination ••~11 -0.36 1. 76 
'lerence ll 1. 42 -0.51 0.89 
e -•t~ -0.81 ~[)( 1. 36 1.11 1. 38 
13 0.44 1. 58 1. 48 
Co111hination ••11 1.34~ 
•t:rall 1. 87 0.80 1. 73 
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Neurometric (QEEG) Discriminants 
Stored T-Score data analysis 
1a is GKl coRpared to GK2 NaRe 1: GKl F Na"e 2: K. Gina 
~opolar Independent Tscore/Diff. 2score Heasures Anal~zed: 86/12/98 
~rees of freedo .. : 74 
. 
- ·• Fpl Fp2 F? re F3 F4 C3 C4 Fps Fz Cs 
--- ---
............ ..... ..; ~OllQ- ..... ~ ........ ~ ............ ·- ... ~ ~ .... ,... . ............... 
•solute A -3.6 -2.9 -5.9 -2.4 -4.1 -3.3 -3.9 -3.9 -4.2 -3.4 -3.7 
'ow er 6 0.2 -0.0 -2.2 0.3 -0.9 -0.3 -2.9 -2.5 0.4 -2.3 -0.4 
score) IX 3.7 2.2 1. 8 2.2 1.? 2.5 -0.2 -1.0 2.1 -8.4 1. 9 
6 5.7 1. 9 1.1 5.8 2.2 3.5 2.8 3.6 2.6 3.1 3.7 
•tlative A -1.5 -1.2 -2.1 -1.3 -1.4 -1.5 -8.9 -1.2 -1.5 -1.4 -0.8 
·•ouer 8 1.1 8.9 1.3 8.6 1.1 1.8 8.5 0.5 1. 5 1.1 8.5 
'.A 2) IX 1. 0 8.7 1.4 8.7 1.8 1.0 8.8 8.6 0.9 8.9 0.6 
6 2.8 1.2 1.8 1.4 1. 6 1.6 1.8 2.1 1.5 2.0 1. 7 
.,ower A -8.5 -1. 9 -8.4 8.4 
IJM"etr~ 8 8.3 -8.9 -8.5 -8.1 
JA 2) IX 1.3 -8.2 -8.5 0.5 
I!> 2.3 -8.8 -8.4 -8.4 
~erence A -2.0 -1. 7 -1.6 -1.9 
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